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GLYCOSYLATION MODULATES CARDIAC EXCITABILITY BY ALTERING 
VOLTAGE-GATED POTASSIUM CURRENTS 
Tara A. Schwetz 
ABSTRACT 
Neuronal, cardiac, and skeletal muscle electrical signaling is achieved through 
the highly regulated activity of several types of voltage-gated ion channels to 
produce an action potential (AP). Voltage-gated potassium (Kv) channels are 
responsible for repolarization of the AP. Kv channels are uniquely and heavily 
glycosylated proteins. Previous reports indicate glycosylation modulates gating of 
some Kv channel isoforms; often, terminal sialic acid residues alter Kv channel 
gating. Here, we questioned whether alterations in glycosylation impact Kv 
channel gating, thus altering APs and cardiac excitability. ST3Gal-IV, a 
sialyltransferase expressed at uniform levels throughout the heart, adds sialic 
acids to N- and O-glycans through α2-3 linkages. Electrocardiograms (ECGs) 
suggest that cardiac conduction/rhythm are altered in ST3Gal-IV(-/-) animals, 
which show an increased incidence of arrhythmic beats. AP waveform 
parameters and two components of IK, the transient outward, Ito, and the slowly 
inactivating, IK,slow, were compared in neonatal control versus ST3Gal-IV(-/-) and 
glycosidase treated atrial and ventricular myocytes. Action potential durations 
(APDs) measured from ST3Gal-IV(-/-) and glycosidase treated atrial myocytes 
xiv 
 
were lengthened significantly (~25-150%) compared to control; however, 
ventricular APDs were unaffected by changes in glycosylation. Consistently, 
atrial Ito and IK,slow activation were shifted to more depolarized potentials (by ~9-
17 mV) in ST3Gal-IV(-/-) and glycosidase treated myocytes, while ventricular K+ 
currents were unaltered. Those channels responsible for producing Ito and IK,slow 
were examined under conditions of full and reduced glycosylation. Sialylation and 
N-glycosylation uniquely and differently impact gating of two mammalian Shaker 
family Kv channel isoforms, Kv1.4 and Kv1.5; Kv1.4 gating was unaffected by 
changes in channel glycosylation, while N-linked sialic acids, acting through 
electrostatic mechanisms, fully account for glycan effects on Kv1.5 gating. In 
addition, sialic acids modulate the gating of three Kv channel isoforms that are 
not N-glycosylated, Kv2.1, Kv4.2, and Kv4.3, through apparent electrostatic 
mechanisms. Click chemistry was utilized to confirm that these three isoforms 
are O-glycosylated and sialylated; thus, O-linked sialylation modulates gating of 
Kv2.1, Kv4.2, and Kv4.3. This study suggests that regulated or aberrant 
glycosylation alters the gating of channels producing IK in a chamber-specific 
manner, thus altering the rate of cardiac repolarization and potentially leading to 
arrhythmias. 
1 
 
 
 
 
CHAPTER 1 
INTRODUCTION 
Diseases of the cardiovascular system are abundant in the United States and 
can be life-threatening. In fact, for several years, cardiovascular disease has 
been reported as the leading cause of death in the United States, with an 
estimated 80.7 million American adults (1 in 3) diagnosed with one or more types 
of cardiovascular disease. One affliction of the cardiovascular system, cardiac 
arrhythmias, affects more than 5 million people nationwide and results in over 
400,000 deaths annually1. Arrhythmias, as well as heart failure, myocardial 
infarction, and other cardiovascular maladies, are associated with alterations in 
normal cardiac ion channel function2-12. Thus, processes governing channel 
gating can potentially impact cardiac excitability. 
 
Action potentials are generated and conducted through the myocardium 
Cardiac conduction and contraction can be investigated by measurement of 
electrical signals produced across the surface of the heart utilizing an 
electrocardiogram (ECG). Distinct phases of the cardiac cycle are represented as 
waves on the ECG. In general, the P wave corresponds to atrial depolarization. 
Atrial repolarization is masked by the QRS complex, which reflects ventricular 
depolarization. Ventricular repolarization is represented by the T wave (Figure 
1.1). Each P-T segment denotes one full heart beat.  
2 
 
Figure 1.1. The action potential waveform is modified throughout the 
myocardium. 
 
0
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Figure 1.1. Representation of action potential waveform variation across different 
regions of the heart and the corresponding electrocardiogram (ECG) waves. 
Differential expression of ion channels is thought to account for these 
differences. Slow and fast action potential phases are numbered. Action 
potentials are displaced to signify the sequential firing through the myocardium 
3 
 
and are aligned with the resulting ECG wave. SA: sinoatrial; AV: atrioventricular; 
RV: right ventricle; LV: left ventricle. Figure modified from Nerbonne and Kass, 
200513.  
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Electrical signals, measured cellularly as action potentials (AP), are conducted 
through the heart from the sinoatrial (SA) node, depolarizing through the 
ventricles, and subsequently repolarizing in an opposite fashion (Figure 1.2). If 
this signal or path is disrupted at any location, alterations in normal contraction 
and conduction can result, potentially leading to arrhythmias. Therefore, proper 
action potential production is an important component of normal cardiac rhythm. 
 
Action potentials, the rapid depolarization and subsequent repolarization of the 
membrane, are generated by the regulated opening and closing of voltage-gated 
ion channels producing electrical currents (Figure 1.3). Cardiac action potentials 
are categorized as fast or slow APs by their waveform and the ion channels 
underlying their production. In phase 0 of the fast AP, voltage-gated sodium (Nav) 
channels open and cause a rapid depolarization of the membrane, due to 
movement of sodium (Na+) ions into the cell down their electrochemical gradient. 
Nav channels inactivate whilst voltage-gated potassium (Kv) channels activate to 
produce a transient outward current (Ito), resulting in the slight, rapid 
repolarization observed in phase 1. During the plateau phase (phase 2), voltage-
gated calcium (Cav) channels activate, generating an inward current that is 
counterbalanced by an outward potassium (K+) current (human IKs). In phase 3, 
the outward K+ current, corresponding to IKr and IKur in humans and IK,slow in the 
mouse, begins to exceed the inward calcium current; the cell is repolarized back 
toward the resting membrane potential as a result. The ensuing diastolic potential  
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Figure 1.2. Electrical conduction through the heart. 
 
 
 
Figure 1.2. Electrical signals that generate the heart beat originate in the 
sinoatrial (SA) node and depolarize the ventricles via passage through the 
atrioventricular (AV) node, subsequently repolarizing in the reverse direction. 
Figure from Kerwin, 2007. http://afibcryoablation.com/types.of.arrhythmia.asp.  
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is produced by the outward K+ current equaling the action of the Na+/K+-ATPase, 
which pumps K+ ions into the cell (phase 4) (Figure 1.3). 
 
Although generated in a similar manner to fast APs, slow APs are produced by 
different ion channels and consist of three phases. In phase 0, Cav channels 
depolarize the membrane, activating Kv channels to commence repolarization 
(phase 3). A constant inward current (If) drives the membrane toward more 
positive potentials in phase 4, creating a diastolic depolarization. The diastolic 
depolarization allows for the maintenance of consistency and rhythm and is an 
important characteristic of pacemaker cells (Figure 1.1)14. 
 
Variation in AP waveform is due to differential expression of numerous ion 
channel isoforms throughout the heart. For example, fast action potentials, 
described above, are produced in the purkinje fibers and epicardium. In the 
sinoatrial and atrioventricular (AV) nodes, slow AP’s predominate (Figure 1.1)15. 
Furthermore, the AP waveform varies between the atria and ventricles, as 
demonstrated by the distinct phase 2 shape (Figures 1.1 and 1.3)16. In fact, 
differing cardiac AP waveforms can be observed throughout the developing 
myocardium17-20. Alterations in the type, relative density, or activity of ion 
channels can modify the waveform of the AP through a process often referred to 
as remodeling15,16,21.  
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Figure 1.3. Human atrial and ventricular action potentials and the ionic 
basis of their production. 
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Figure 1.3. Schematic of human atrial (blue) and ventricular (red) action 
potentials and the corresponding currents and the known or postulated (?) ion 
channels underlying the macroscopic currents (left and right, respectively). 
Several of the currents involved in atrial and ventricular action potential 
production overlap, as indicated in purple. Note the phase in which each current 
contributes. Figure modified from Pond and Nerbonne, 200116.  
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Remodeling of the myocardium is involved in normal processes and 
pathologies 
The term remodeling refers to a change in cellular processes resulting from 
altered protein expression and is characteristic of normal cardiac development 
and pathologies2-12,17-19,22-30. In fact, human prenatal cardiac rhythm is typically 
between 120 and 160 beats per minute (bpm), while the average adult heart rate 
is 72 bpm; this slowing of cardiac rhythm is demonstrative of cardiac remodeling 
throughout development and likely due to autonomic innervation and ion channel 
remodeling31-36.  
 
Several cardiac pathologies are the consequence of electrical and structural 
remodeling. In fact, electrical remodeling perpetuates and maintains atrial 
fibrillation (AF), the most prevalent sustained arrhythmia in the United States37-39. 
Current densities of calcium (ICa), sodium (INa), and transient outward (Ito) 
currents are significantly reduced in canine models of AF and in patients with 
permanent AF9,10,40-43. Consistently, parallel reductions in the relative expression 
levels of mRNA encoding the channel isoforms responsible for producing the 
aforementioned currents are observed in AF models44. A significant reduction in 
the current density of the ultrarapid delayed rectifier potassium current (IKur) has 
been shown in myocytes from patients with persistent AF, as well as decreased 
protein levels of the responsible channel isoform10,45.  
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Additionally, left ventricular hypertrophy (LVH), an adaptive myocardial response 
to increased load, is associated with prolongation of the ventricular AP due to 
remodeling of K+ channels46-48. IK,slow and Iss current densities and amplitudes are 
lower in mouse models of LVH and mRNA levels of the corresponding Kv 
channels, Kv1.5, Kv2.1, and TREK1, are altered as well49. Ionic currents and 
glycosylation, one form of post-translational modification, are altered in heart 
failure (HF) models, illustrating the prevalence of remodeling in cardiac 
pathologies50-57.  
 
Alterations in ion channel function can impact excitability, resulting in 
pathological consequences 
Voltage-gated ion channels contribute to AP initiation and propagation in 
excitable cells. Thus, changes in the function of voltage-gated ion channels can 
impact cardiac, neuronal, and skeletal muscle AP waveform and duration. 
Pathologies such as Long QT Syndrome (LQTS), deafness, and epilepsy can be 
produced by changes in ion channel function or distribution58-66. The focus of this 
study will be cardiac maladies. 
 
Mutations in eight different genes are correlated to LQTS, which is characterized 
by delayed ventricular repolarization or a lengthened QT interval on the 
electrocardiogram (Figure 1.4). In most instances, LQTS is generated by loss of 
potassium channel function or gain of function in sodium channels resulting from 
mutations in the alpha subunit of the channel protein, beta/accessory subunits, or  
11 
 
Figure 1.4. Electrocardiogram recordings of cardiac irregularities. 
 
 
 
Figure 1.4. Abnormal ECGs in humans and genetically engineered mice. LQT: 
prolonged QT interval; TdP: torsade-de-pointe episode; We: Wenckebach 
atrioventricular (AV) block; Avb: high degree AV block. Figure from Nerbonne, et 
al., 200167. 
 
 
 
 
 
12 
 
modulatory proteins. For example, mutations in the genes coding for KvLQT1 
(KCNQ1) and hERG, respectively responsible for production of IKs and IKr, can 
induce a reduction or loss of these currents, thereby decreasing the repolarizing 
current during the AP and leading to LQTS. Disruption of sodium channel 
inactivation, brought on by mutations of the channel protein, is causative of LQTS 
as well68-70. Furthermore, slight changes in ion channel genes, termed 
polymorphisms, may play a role in the varied response of patients carrying the 
modified gene to pharmaceutical agents; acquired or drug-induced Long QT 
Syndrome can result71. Unlike LQTS, Brugada Syndrome, characterized by right 
bundle branch block, ST interval elevation, and ventricular tachyarrhythmias, 
results from loss of Na+ channel function and decreased INa72. Brugada 
Syndrome can be caused by mutations in the cardiac sodium channel, 
Nav1.573,74.  
 
Members of the diverse potassium channel family function similarly 
The potassium channel family is a large and varied designation of ion channels 
(Figure 1.5). In fact, isoforms of potassium channels exist in bacteria, plants, and 
metazoan animals75; multiple, distinct K+ channels have been identified in 
evolutionarily early metazoan animals76. The greatest diversification of K+ 
channels is among voltage-gated K+ channels. Kv channels differ in many facets, 
including activation kinetics, ability to inactivate, and modulation by accessory 
subunits and intracellular messengers.  
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Figure 1.5. Diversity of K+ channels. 
 
 
 
Figure 1.5. Potassium channels are a large and varied ion channel class. The 
most general grouping arranges the channels by membrane topology (2TM, 
4TM, 6TM). Branching reflects the predicted evolutionary relationships. The red 
box highlights the main classification of voltage-gated potassium (Kv) channels. 
Figure from Hille, 200175. 
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The primary responsibilities of K+ channels are to set the resting membrane 
potential and repolarize the cell subsequent to a depolarization by allowing the 
flow of potassium ions out of the cell; in general, these channels stabilize the 
membrane potential by drawing it toward the potassium equilibrium potential and, 
thus, away from the firing threshold. Several subfamilies of voltage-gated 
potassium (Kv) channels exist and each performs this task (of repolarization) in a 
unique manner. Kv channels do, however, maintain a consistent, homologous 
structure. The alpha subunit, or primary protein sequence encoding the pore-
forming subunit, is a tetramer of six transmembrane domains that join to form a 
functional channel. In addition, each monomer contains a voltage-sensor (S1-S4) 
and a pore-forming loop (S5-S6 linker) (Figure 1.6). 
 
The voltage sensor includes the first through fourth transmembrane domains 
(S1-S4), with the S4 segment carrying much of the gating charge. The S4 
segment contains positively charged amino acids (arginine and lysine) termed 
gating charges at approximately every third residue; the first four arginines 
account for most of the gating charge. Approximately twelve to fourteen electron 
charges per tetrameric K+ channel (or 3 to 3.5 per subunit) cross the membrane 
voltage difference and constitute the gating charge77-79. The positive gating 
charges on the S4 segment are repelled through the membrane in the 
extracellular direction when the membrane is depolarized, allowing the channel 
to open75,80. Currently, two schools of thought exist as to how this is performed; 
however, it is widely accepted that amino acid residues of the S4 segment move  
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Figure 1.6. Schematic of voltage-gated potassium channel structure. 
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Figure 1.6. Depiction of Kv channel structure and tetramerization. A. A single 
subunit of Kv channels. Important structural aspects are noted, including the 
positively charged voltage sensor (orange) and the pore loop (purple). B. An 
enlarged image of the pore loop, linking the fifth and sixth transmembrane 
segments (S5 and S6). C. Illustration of the tetramerization of Kv channels. Four 
subunits converge to form a functional channel. Ions move through the pore and 
are selected for passage through the channel via the selectivity filters. Figure 
adapted from Purves, 200481. 
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towards the extracellular surface during a gating event82. The first theory, the 
conventional theory, describes the S4 segment as a cylindrical structure located 
within a water-filled column formed by the other voltage-sensing segments (S1-
S3). With a depolarization, the S4 segment is propelled outward, perpendicular to 
the membrane (Figure 1.7A). In 2003, the MacKinnon group proposed that the 
S4 segment forms a paddle-like structure that rotates through the hydrophobic 
membrane toward the extracellular space, resulting in a conformational change 
of the pore-forming segments; this conformational change opens the channel 
(Figure 1.7B). Crystal structures of KvAP and Kv1.2 have substantiated this 
claim83-85.  Although the theories share distinct similarities (in both models, the S4 
segment is repelled in the extracellular direction through the lipid bilayer), much 
debate exists as to which is correct, with published data supporting both  
claims83-97. 
 
In addition to a voltage-sensor, Kv channels contain a pore-forming subunit, 
composed of the S5 and S6 segments, which line the pore. The extracellular 
linker between these segments forms a P-loop, dipping into the pore (Figure 1.6). 
One distinct and unique feature of most potassium channels is their “signature 
sequence,” located within the P-loop. The consensus amino acid sequence is –
Thr-X-X-Thr-X-Gly-Tyr-Gly-Glu (TXXTXGYGD), where X is any amino acid98-100. 
Specifically, the residues Thr-X-Gly-Tyr-Gly (TXGYG) line the selectivity filter and 
are repeated on all four subunits. As the name suggests, the selectivity filter 
allows for the selection of potassium ions through the pore. Most K+ channels are  
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Figure 1.7. Representation of the voltage-sensor (S4) movement. 
 
B
A
 
 
Figure 1.7. The S4 segment moves through the membrane in response to a 
changing membrane potential, activating the channel. A. The conventional model 
describes the S4 segments as cylinders moving perpendicular to the membrane. 
B. The new model portrays the S4 segments as paddles rotating through the lipid 
membrane. += positively charged amino acid residues within the primary protein 
structure. Figure from Jiang, et al., 200383.  
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permeable to only four cations—K+, Tl+, Rb+, and NH4+—and are blocked by Cs+ 
because the selectivity filter is too narrow to allow for the passage of this larger 
cation75. Additionally, K+ channels are considered to have a long pore, with 
permeant ions lining up inside the pore in single file for passage; this is known as 
single-file diffusion101,102. This study concentrates on two types of voltage-gated 
potassium channels, delayed rectifiers and A-type channels, which can be 
blocked by the pharmaceutical agents tetraethylammonium (TEA) and 4-
aminopyridine (4-AP), among others103-106.  
 
Delayed rectifiers and KA channels contribute to the generation of voltage-
gated potassium currents 
Delayed rectifiers, also termed Kv channels, were first called thus because they 
change the membrane conductance with a delay following depolarization107. Due 
to the complexity of Kv channels, a nomenclature of Kvm.n, where m denotes the 
subfamily and n is the order of discovery, has been devised (Figure 1.5). For 
example, Kv1.5 is the fifth member of the Shaker subfamily of vertebrate Kv 
channels108. Most delayed rectifiers generate a rapidly activating, slowly 
inactivating current, IK,slow and Iss in mouse atria and ventricles and IKur in human 
atria. In murine ventricular myocytes, two distinct components of IK,slow have been 
discovered, IK,slow1 and IK,slow2, which are produced by different Kv channel 
isoforms109-112. Both partially are responsible for the repolarizing currents 
generated in phase 3 of the murine AP (Figure 1.8)109,113,114. Interestingly, IKur 
(AP phase 3) is undetectable in ventricular myocytes of most species and is  
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Figure 1.8. Human and murine ventricular action potentials are generated 
by similar currents.  
 
A B
 
 
Figure 1.8. A variety of ionic currents produce human (A) and mouse (B) 
ventricular action potentials. A considerable array of cardiac K+ currents 
repolarize the membrane. Figure from Nerbonne, 2004115. 
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considered a potential target for the treatment of atrial arrhythmias116-122. IKr and 
IKs are human delayed rectifier potassium currents principally expressed in the 
ventricles and involved in phases 2 and 3 of the action potential, respectively; IKr 
activates rapidly, inactivates even more rapidly, and exhibits inward rectification, 
while IKs activates slowly and displays no inward rectification (Figure 1.8)123,124. 
Most delayed rectifiers undergo C-type inactivation, a conformational change in 
the protein structure at the extracellular region of the pore, namely the outermost 
segment of the selectivity filter, causing it to close (Figure 1.9B)75.  
 
A-type K+ channels (KA), a subset of Kv channels, produce a rapidly activating 
and inactivating transient outward current, referred to as IA or Ito (Figure 1.8). 
From here on, this current will be referred to by the latter term, as it is the more 
widely accepted designation. Two components of transient outward current with 
distinct properties have been found and are termed Ito,fast (Ito,f) and Ito,slow 
(Ito,s)125,126. Typically, Ito,s recovers from inactivation at a much slower rate than 
Ito,f. The two currents are produced by functionally different channels, but are, 
however, difficult to study individually126-128. KA channels (generating both Ito,f and 
Ito,s) activate transiently in the subthreshold range of membrane potentials129-133. 
Typically, KA channels activate upon depolarization of the membrane, 
subsequent to a period of hyperpolarization, and inactivate prior to closing. Ito 
channels undergo rapid N-type inactivation, otherwise known as the ball-and-
chain method of inactivation. In this method, the N-terminus occludes the pore, 
causing the channel to inactivate (Figure 1.9A). The positively charged ball,  
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Figure 1.9. Kv channels can inactivate through two mechanisms.  
 
 
 
Figure 1.9. Illustration of Kv channel N- and C-type inactivation. A. N-type 
inactivation follows activation and is otherwise known as the ball and chain 
method of inactivation. The first 22 residues of the N-terminus, or ball region, 
occludes the pore, blocking the flow of ions. B. The mechanism underlying C-
type inactivation, or slow inactivation, involves conformational changes in the 
extracellular mouth of the pore, closing the channel. Figure from Rasmusson, et 
al., 1998134.  
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which consists of the first 22 residues of the N-terminus, is necessary for 
inactivation to ensue. In fact, experiments demonstrated that merely one ball 
peptide per channel is adequate to inactivate the channel, albeit at a reduced 
inactivation rate (decreased to 25% of the original rate)135. The next 60 amino 
acids constitute the chain, the length of which determines the rate of inactivation. 
If the chain is lengthened, the ball locates the receptor more slowly; conversely, 
shortening the chain will allow the ball to find the receptor more rapidly. The 
channels producing Ito inactivate at relatively hyperpolarized potentials; therefore, 
Ito can be separated from the total outward current by applying a pre-pulse 
potential to eliminate Ito. The resulting currents can be subtracted from currents 
elicited without the inactivating pre-pulse in order to examine Ito133. This property 
of Ito allows for its involvement in phase 1 of the cardiac action potential (Figure 
1.8). 
 
Kv channel isoforms responsible for production of Ito and IK,slow are 
expressed differentially throughout the myocardium 
Several different Kv channel isoforms, each with distinct time- and voltage-
dependent properties, generate IK,slow and Ito. This study concentrates on five Kv 
channel isoforms, two underlying IK,slow and three producing Ito in murine 
myocytes. IK,slow1 previously was shown to be produced by Kv1.5 (gene KCNA5, 
subfamily Shaker), due to the selective elimination of IK,slow1 from mouse 
ventricular myocytes when Kv1.5 is deleted136,137. Similarly, Kv1.5 encodes the 
atrial-selective IKur in rat, canine, and human myocytes121,122,138-140. IK,slow2 is  
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Table 1.1. The diversity of Kv channels and Kv currents throughout the 
mammalian heart. 
 
Kv Channel 
Subfamily 
Isoform Gene Cardiac 
Current 
Tissue* Species* 
Kv1/Shaker Kv1.4 KCNA4 Ito,s Atrium Rabbit 
Ventricle Mouse, Rat, 
Rabbit, Ferret, 
Human 
Node Rabbit 
Septum Mouse 
Kv1.5 KCNA5 IKur Atrium Rat, Dog, Human 
IK,slow1 Atrium Mouse 
 Ventricle Mouse 
Kv2/Shab Kv2.1 KCNB1 IK,slow2 Ventricle Mouse 
Kv4/Shal Kv4.2 KCND2 Ito,f Atrium Mouse, Rat 
Ventricle Mouse, Rat 
Kv4.3 KCND3 Ito,f Atrium Mouse, Rat, Dog, 
Human 
Ventricle Mouse, Rat, Dog, 
Human 
 
Table 1.1. The table indicates the Kv channel and the current produced by the 
channel in each area of the heart in various species. * = Currents have been 
identified in these tissue types/species. Table modified from Nerbonne, 200015. 
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generated by Kv2.1 (gene KCNB1, subfamily Shab), with similar mRNA 
expression levels in the mouse atria and ventricles111,113,141. A great deal of 
evidence points to Kv4 alpha subunits as those responsible for production of Ito,f. 
Kv4.3 (gene KCND3, subfamily Shal) mRNA expression levels are detectable at 
similar levels in mouse atria and ventricle, while Kv4.2 (gene KCND2, subfamily 
Shal) expression is higher in the ventricles141. Kv4.2 and Kv4.3 were thought to 
associate in the mouse ventricle, suggesting heteromeric assembly of these two 
isoforms produces functional ventricular Ito,f. However, recent data suggest that 
Kv4.3 is not required for the generation of mouse ventricular Ito,f, through 
utilization of a Kv4.3(-/-) animal model142,143. In human and canine myocardium, 
Kv4.2 is not expressed; therefore, Ito,f is thought to be produced by Kv4.3 
channels144,145. In contrast, Ito,s is encoded by Kv1.4 (gene KCNA4, subfamily 
Shaker) in mouse, rat, ferret, canine, and human ventricular myocytes and rabbit 
atrial myocytes; however, in the murine myocardium, Kv1.4 appears to be 
primarily expressed in the interventricular septum (Table 1.1)146-152. The 
differential expression of these Kv isoforms throughout the myocardium parallels 
the variation in AP waveform in different regions of the heart.  
 
Kv channels are post-translationally modified 
Voltage-gated ion channels are heavily post-translationally modified proteins; 
glycosylation, fatty acylation, phosphorylation, nitrosylation, and sulfonation can 
be attached to these channels. Importantly, glycosylation constitutes 
approximately 30% of the mass of an ion channel153-158. Studies have suggested  
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that hundreds of sugar residues per functional molecule are attached to Na+ 
channel and some Shaker K+ channel proteins154,159-164. Furthermore, greater 
than 1% of the human genome is involved in glycosylation, equating to about 500 
proteins aiding in the addition and removal of glycans165. The Consortium for 
Functional Glycomics (CFG) recognizes 503 human genes involved in 
glycosylation. Due to the large number of genes involved in glycosylation, 
alterations in normal gene expression could cause variations in the type or 
amount of glycosylation added to proteins or lipids.  
 
The impact of glycosylation is significant throughout development and 
disease 
The surfaces of most types of cells are heavily decorated with various types of 
glycoconjugates, with glycosylation attached to proteins and lipids. The biological 
and physiological roles of glycosylation are diverse due to their complexity and 
ubiquitous presence. Glycosylation plays protective, stabilizing, organizational, 
and barrier roles. Further, glycan involvement in protein trafficking, secretion, 
immunity, cell adhesion, receptor activation, and endocytosis has been 
established166,167. In fact, the ABO blood types (A, AB, B, O) are characterized as 
such based on their glycan structures, which behave as antigens. In this way, 
type B blood given to a patient with type A blood antigens will result in an 
adverse reaction.  
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Two general forms of glycosylation have been identified—N-linked and O-linked 
glycosylation. Unlike protein synthesis, glycosylation is not template-driven. 
However, the addition of glycosylation is a highly ordered and complex process; 
the product of one enzyme determines the next enzyme in the synthesis reaction 
and, therefore, the subsequent substrate. Catabolic glycosidases and anabolic 
glycosyltransferases share equally important roles, as both are required for 
glycosylation of proteins and lipids.  
 
N-glycosylation, so named because of its attachment to an asparagine residue 
(Asn or N), initiates in the endoplasmic reticulum. An oligosaccharide precursor, 
composed of two core N-acetylglucosamines (GlcNAc) and five mannose 
residues, is linked to a dolichol-phosphate on the cytosolic side of the 
endoplasmic reticulum (ER). The lipid-linked precursor then is flipped across the 
lipid bilayer into the lumen of the ER, through a process that is not wholly 
understood. With the addition of mannose and glucose residues, construction of 
the dolichol oligosaccharide precursor is complete. A multi-subunit protein 
complex, termed oligosaccharyltransferase (OST), transfers the dolichol 
oligosaccharide precursor en bloc to an asparagine residue on a nascently 
translated protein (Figure 1.10). The minimal sequence requirement for the 
acceptor asparagine and its neighboring residues is the tripeptide sequon Asn-
Xaa-Ser/Thr (NXS/T), where X is any amino acid with the exception of proline; 
this is referred to as the N-glycosylation consensus sequence168-170. Following 
covalent attachment of the oligosaccharide precursor to the Asn residue,  
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Figure 1.10. N-glycan biosynthesis in the Endoplasmic Reticulum. 
 
 
 
Figure 1.10. Schematic of N-glycan synthesis and en bloc transfer to nascent 
proteins via oligosaccharyltransferase (OST) in the Endoplasmic Reticulum (ER). 
An oligosaccharide precursor is linked to a dolichol-phosphate on the cytosolic 
side of the ER before flipping across the lipid bilayer into the lumen. Once in the 
lumen, further processing and transfer to an asparagine residue of a newly 
synthesized protein occurs. Figure adapted from Freeze and Aebi, 2005171. 
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glucosidases sequentially remove all glucose residues. At this point, improperly 
folded proteins are reglucosylated, where they are retained in the ER to be 
refolded or degraded. The newly glycosylated protein (glycoprotein) is 
translocated to the cis-Golgi, where the mannoses are trimmed. Formation of 
complex glycans occurs in the medial and trans-Golgi, where addition of sialic 
acid (SA) terminates the process168-170,172,173. Sialic acids, negatively charged 
residues at physiologic pH, can be attached to other sialic acid residues, forming 
a poly-sialic acid structure; this structure can contribute a substantial negative 
charge to the protein.  
 
Synthesis of the other form of glycosylation, O-glycosylation, is not as well 
described as N-glycan biosynthesis. Although no recognized consensus 
sequence has been identified, some predictive markers have been documented; 
furthermore, sites of O-glycosylation can be identified with only 70% precision174. 
O-glycans are attached to serine or threonine residues, with prolines, alanines, 
serines, and threonines commonly found as neighboring residues. Prolines 
promote the formation of β-turns and β-sheets and O-glycans are located largely 
at the predicted β-turns175-183. The complexity of O-glycan biosynthesis is great, 
as a large number of genes (as many as 24 N-acetyl-α-
galactosaminyltransferases) can commence the process184-186. The most 
prevalent form of O-glycosylation, the mucin type, initiates in the ER and refers to 
an N-acetylgalactosamine (GalNAc) α-linked to the hydroxyl group of a serine or 
threonine; the addition of a galactose β1-3 linked to GalNAc occurs in the Golgi  
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Figure 1.11. Biosynthesis of mammalian O-glycans. 
 
 
 
Figure 1.11. The synthesis of mammalian mucin type O-glycans initiates in the 
Endoplasmic Reticulum with the addition of N-acetylgalactosamine (GalNAc) 
onto the hydroxyl group of a serine (S) or threonine (T). Enzymes responsible for 
each substrate are shown. Further extension is not shown, including addition of 
sialic acid. Figure adapted from Tian and Ten Hagen, 2008187. 
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(Figure 1.11)184,185. O-glycosylation structures can be further extended and 
compounded upon, similar to that of N-glycosylation. In general, however, O-
glycans have a propensity to be less branched than their N-linked counterparts, 
but are commonly biantennary structures terminated by sialic acid residues.   
 
Throughout developmental and pathological states, glycosylation, including 
glycogene expression, is regulated in various tissue types. The brain, thymus, 
lymph nodes, lung, liver, kidney, spleen, testes, and bone marrow express 
distinct glycogene patterns and glycosylation structures188. Moreover, glycogene 
profiles are unique in each stage of development in the cerebral cortex and 
myocardium189,190. Abnormalities in glycosylation are linked to a multitude of 
disorders, generally targeting the neuronal, muscular, and cardiovascular 
systems. A collection of diseases designated Congenital Disorders of 
Glycosylation (CDG) are heterogeneous autosomal recessive metabolic 
glycosylation disorders, resulting in protein defects. Currently, 28 types of CDG 
have been identified, which result from alterations in both N- and O-linked 
glycosylation; 16 forms are associated with N-glycosylation, 6 with O-
glycosylation, 4 with N- and O-glycosylation, and 2 types impact glycolipids191. All 
28 CDGs result in reduced sialylation and the simplest, most reliable indicator of 
CDG is isoelectric focusing analysis of serum transferrin sialylation. Specifically, 
CDG-IIf, a fatal disorder, is caused by a deficiency in the CMP-sialic acid 
transporter, resulting in loss of sialyl-Lex antigen192. Defects in the GNE/MNK 
gene influence the sialylation of only O-glycans and mutations in this gene have 
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been described in Nonaka myopathy and sialuria. Nonaka myopathy, in which O-
glycan sialylation levels are decreased by 60-80%, presents as myopathic 
weakness and limb atrophy193. Conversely, hypersialylation of O-glycosylation 
structures and increased concentrations of urinary and fibroblastic free sialic acid 
occur in patients with sialuria, with symptoms of mild psychomotor delay, 
persistent upper respiratory tract infections, and hepatomegaly194-196. In addition, 
alterations in normal glycosylation patterns contribute to familial tumoral 
calcinosis and IgA nephropathy197-205. 
 
Chagas disease, a parasitic disorder transmitted through insect bites and caused 
by Trypanosoma cruzi (T. cruzi), afflicts more than 18 million people worldwide. 
Chronic fibrotic myocarditis, commonly leading to cardiac arrhythmias and 
insufficiency, and degeneration of autonomic nervous system innervated tissues 
are hallmarks of Chagas disease. T. cruzi cleaves sialic acid residues from host 
cells via release of a trans-sialidase and subsequently utilizes the sialic acids for 
its own requirements; this is believed to be an origin of the symptoms of Chagas 
disease206-208. Due to the ubiquitous and abundant nature of glycosylation, 
remodeling of N- or O-glycans (including sialic acids) could potentially affect the 
function of glycoproteins, particularly the gating of ion channels. 
 
Changes in glycosylation can alter the gating of ion channels 
As previously stated, voltage-gated ion channels are heavily glycosylated 
proteins, with the number and location of glycosylation sites varying among 
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channel isoforms. For example, Nav1.5, a cardiac sodium channel, contains 13 
putative N-glycosylation sites on its extracellular linkers22,209. Many Kv channel 
isoforms are N-glycosylated as well. Kv1.4 and Kv1.5, Shaker Kv channel 
isoforms, possess one N-glycosylation site on their S1-S2 extracellular linkers. 
Interestingly, these sites are located only six amino acids apart210. The sole N-
glycosylation site for Kv2.1, a Shab Kv channel, is positioned on its S3-S4 linker 
(Figure 1.12); much debate surrounding the glycosylation of this site exists due to 
its location, which may or may not be located within the membrane (based on the 
new structural model). If so, it may be inaccessible to the cell’s glycosylation 
machinery and therefore, not N-glycosylated84,85,211. Conversely, Kv4 channel 
isoforms, including Kv4.2 and Kv4.3, do not contain external N-glycosylation sites 
and cannot be N-glycosylated. However, voltage-gated ion channels have the 
potential to be O-glycosylated, whether a putative N-glycosylation site is present 
or not; that being said, sialylation may be present on most, if not all, voltage-
gated channels. 
 
The surface potential theory, initially developed by Frankenhaeuser and Hodgkin 
and expanded upon by Hille et al, postulates that negative charges on the 
external surface of the cell membrane generate a surface potential. These 
negative charges on the extracellular membrane surface may be due to several 
factors, such as sialic acids, charged lipids and proteins, and electrolytic 
screening in solution. Negatively charged sialic acids are the most relevant sugar 
residue influencing ion channel gating. These terminally located sugar residues  
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Figure 1.12. Glycosylation sites of Kv channels are located on the 
extracellular linkers.  
 
Kv2.1
Kv1.5
Kv1.4
 
 
Figure 1.12. Crystal structure of Kv1.2 with glycosylation sites noted. Stereo 
image of Kv1.2 from the extracellular side of the membrane. Arrows point to the 
Kv1.4, Kv1.5 and Kv2.1 potential N-glycosylation sites. Figure modified from Long, 
et al., 200584. 
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are thought to contribute to the external negative surface potential, which can 
impact the voltage experienced by the positively charged S4 segment. As 
previously discussed, the S4 segment contains positively charged amino acids at 
approximately every third residue and when the membrane is depolarized, the S4 
segment is repelled outward, opening the channel. The negatively charged 
surface potential, to which sialic acids potentially contribute, may affect the 
positively charged S4 segment through electrostatic interactions, allowing the 
channel to gate at more hyperpolarized potentials. The reverse holds true as 
well; reducing the sialic acid content will decrease the negative surface potential 
sensed by the S4 voltage-sensor and thus, a greater depolarization will be 
required to activate the channel212,213. In addition, the gating stabilizing theory 
predicts that a change in the conductance-voltage (G-V) slope denotes an 
alteration in functional state stability. Thus, modifications in glycosylation can 
affect channel gating by shifting the voltage of half-activation (Va) and altering the 
slope75. 
 
Several previous studies suggest that alterations in glycosylation, specifically 
sialylation, can impact ion channel gating. In Chinese Hamster Ovary (CHO) 
cells, gating of Nav and Kv channels is modulated by a reduction in glycosylation. 
For example, gating of Nav1.4 and the Shaker Kv channel isoforms, Kv1.1, Kv1.2, 
and the Drosophila ShB channel, is shifted to more depolarized potentials with a 
reduction in sialylation and N-glycosylation163,209,214-216. Additionally, steady-state 
activation and inactivation of Kv4.3 were shifted in the depolarized direction when 
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expressed in CHO cells with a decreased ability to sialylate proteins. Currents 
recorded from cardiomyocytes were modulated upon treatment with glycosidases 
as well. The Kv current Ito was decreased in amplitude and the voltage of 
activation was shifted to depolarized potentials in adult murine ventricular 
myocytes upon treatment with neuraminidase to cleave sialic acid residues; 
consistently, action potential durations were prolonged in neuraminidase-treated 
adult ventricular myocytes217. Myocardial Nav currents also are impacted by 
desialylation, demonstrating depolarizing shifts in gating57,218. Additionally, data 
suggest that rat neonatal and adult atrial and adult ventricular Nav channels are 
more sialylated and thus, more affected by changes in sialylation than neonatal 
ventricular Nav channels218. Therefore, effects of glycosylation on ion channel 
gating are isoform-specific. 
 
As formerly mentioned, several glycosylation disorders can severely impact 
normal functioning of the cardiovascular system, altering cardiac conduction and 
rhythm. Previously, no study has detailed the effects of changes in Kv channel 
glycosylation on cardiac excitability. Here, we utilized in vivo and in vitro 
techniques to determine whether regulated or aberrant glycosylation 
(concentrating on sialylation) affect cardiac Kv currents and, as a consequence, 
cardiac excitability. In chapter three, ECGs, cardiac APs, and two repolarizing Kv 
currents (Ito and IK,slow) were examined utilizing a knockout mouse model deficient 
in a single sialyltransferase, ST3Gal-IV. ST3Gal-IV, a sialyltransferase (ST) that 
is localized to the Golgi, adds α2-3 linked sialic acids to N- and O-glycosylation 
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structures219. Cardiac APs and Kv currents were measured under control 
conditions and upon enzymatic treatment to remove specific glycan structures in 
chapter four; atrial action potentials and Kv currents were more sensitive to 
changes in glycosylation (specifically, sialylation) than their ventricular 
counterparts. Chapters five and six investigated whether alterations in 
glycosylation impact five cardiac Kv channels responsible for IK,slow and Ito. The 
data confirm the isoform-specific effects of glycosylation on Kv channel gating 
and suggest O-linked sialic acids can impact channel function. These results 
substantiate previously published data and provide novel evidence detailing the 
effect of K+ channel N- and O-glycosylation on cardiac excitability; this is the first 
study to show O-glycans modulate ion channel gating. An improved 
understanding of how cardiac K+ channel function is modulated advances the 
insight into how alterations in normal processes lead to pathologies. 
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CHAPTER 2 
MATERIALS AND METHODS 
Chinese Hamster Ovary Cell Culture and Transfection  
Pro5 and Lec2 cells were grown in minimal media and transfected with channel 
cDNA as previously described220-223. Briefly, the cells were plated at 25-50% 
confluence on 35 mm dishes 24 hours prior to transfection with 1ml Opti-MEM 
(Invitrogen) containing 8 μl of lipofectamine (Invitrogen), 2.0 μg of eGFP, and 2.5 
μg of channel cDNA and incubated at 37°C in a 5% CO2 humidified incubator. 24 
hours post-transfection, the media was replaced with growth medium, consisting 
of alpha-minimum essential medium (αMEM; Invitrogen) with (Pro5) and without 
(Lec2) ribo- and deoxyribonucleosides supplemented with 10% fetal bovine 
serum (FBS; Hyclone), 100 U ml-1 penicillin, and 100 µg ml-1 streptomycin 
(Mediatech). Cells were incubated at 37°C for another 48 hours prior to 
commencing electrophysiological recordings. 
 
Vector Construction and Mutagenesis 
The hKv1.4, hKv1.5, rKv2.1, rKv4.2, and rKv4.3 open reading frame (ORF) 
inserted into either pRC-CMV or pcDNA 3.1 (Invitrogen) were a gift from Dr. 
Stephen Korn (NIH, formerly University of Connecticut) and Dr. Jean Nerbonne 
(George Washington University). Vector construction and mutagenesis were 
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performed similar to that previously described221,222.  Generally, the cDNA 
containing the α-subunit open reading frame was inserted into pcDNA3.1. 
Mutagenesis was completed using the Stratagene Quickchange IIXL site-
directed mutagenesis kit and mutant constructs were verified through sequencing 
(see table below, bold text = N-glycosylation site mutated). 
 
Mutagenesis Primer Sequences 
Mutant Forward Primer Reverse Primer 
Kv1.4N354Q GGT GGG TTG TTGCAA GAT ACT 
TCA GCA CCC CAT C 
GAT GGG GTG CTG AAG TAT CTT 
GCA ACA ACC CAC C 
Kv1.5N290Q GCC CGC CCC TGG GGC CCA AGG 
CAG CGG GGT CAT GG 
CCA TGA CCC CGC TGC CTT GGG 
CCC CAG GGG CGG GC 
Kv1.5S292A GCC CGC CCC TGG GGC CAA CGG 
CGC CGG GGT CAT GG 
CCA TGA CCC CGG CGC CGT TGG 
CCC CAG GGG CGG GC 
Kv2.1N283Q CCT CAC AGA ATC CCA AAA GAG 
CGT GCT GC  
GCA GCA CGC TCT TTT GGG ATT CTG 
TGA GG 
 
Transgenic Mice 
The sialyltransferase knockout strain, ST3Gal-IV, was originally supplied to us in 
collaboration with Dr. Jamey Marth (University of California San Diego)219,224. The 
mice were housed and cared for in the animal care facilities at the University of 
South Florida, College of Medicine. All protocols have been accepted by the 
Institutional Animal Care and Use Committee. Genotypes of neonatal mice (2-3 
days postnatal) were determined prior to tissue or cell isolation by acquiring tail 
clips, extracting the deoxyribonucleic acid (DNA), and performing polymerase 
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chain reaction (PCR) experiments using the REDExtract-N-Amp Tissue PCR Kit 
(Sigma).  
 
Neonatal Cardiomyocyte Isolation for Electrophysiology 
The cardiomyocyte isolation protocol was adapted from a previously described 
method225. Postnatal day 2-3 mice were euthanized and whole hearts excised 
and placed in 0 Ca2+Tyrode’s Solution. Atria and ventricles were cautiously 
dissected and digested in 1.5 ml of 0.08% Type I Collagenase (Sigma) per ml 0 
Ca2+Tyrode’s Solution at 37ºC in a 5% CO2 humidified incubator for 40 and 30 
minutes, respectively. Cells were centrifuged at 160 x g for 5 minutes and the 
supernatant was replaced with fresh collagenase solution. After gentle trituration, 
atrial and ventricular cells were incubated at 37ºC for 30 and 20 minutes, 
respectively, followed by centrifugation for 5 minutes at 160 x g. The supernatant 
then was replaced by Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10% fetal bovine serum, 100 U ml-1 penicillin, and 100 µgml-1 
streptomycin. The cell samples were triturated, incubated at 37°C for 20 minutes 
to stop digestion, and centrifuged at 160 x g for 5 minutes. Atrial and ventricular 
cells were plated separately on laminin-coated (Sigma) 35 mm dishes in fresh 
media. 
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Electrophysiology and Data Analysis  
Whole Cell Recordings in CHO Cells 
The Pro5/Lec2 expression system, cell lines of Chinese Hamster Ovary cells, 
has been used successfully to determine the effects of sialic acid on channel 
gating163,214-217,220. The Pro5 cell line allows normal protein sialylation, while the 
Lec2 cell line produces essentially non-sialylated proteins due to a deficiency in 
the CMP-sialic acid transporter226-228. The Lec2 cell line used in this study serves 
as a model for CDG type-IIf192,229-231.  
 
Whole cell current recordings were performed using pulse protocols, solutions, 
whole cell patch clamp techniques, and data analyses as previously 
described209,220-222. An Axon 200B patch-clamp amplifier in combination with a 
CV203BU headstage (Axon Instruments) and a Nikon TE200 inverted 
microscope were used. Pulse acquisition software (HEKA) operating on a 
Pentium III computer (Dell Computers) was utilized for pulse protocol generation. 
The ensuing analog signals were digitized using an ITC-16 AD/DA converter 
(Instrutech). All experiments were conducted at room temperature (~22ºC). 
Drummond capillary tubes were pulled into electrodes with a resistance of 1-2 
MΩ using a Model P-97 Sutter electrode puller. Series resistance was 
compensated 95-98%. The extracellular solution was (mM): 65 NaCl, 5 KCl, 1 
MgCl2, 2 CaCl2, 155 sucrose, 5 glucose, 10 Hepes (pH 7.3), while the 
intracellular solution used was (mM): 70 KCl, 65 KF, 5 NaCl, 1 MgCl2, 10 EGTA, 
5 glucose, 10 Hepes (pH 7.3). For the low divalent cation studies, the 
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extracellular solution was identical to that listed above, with the exception of a 0.2 
mM concentration of CaCl2 and a 0.1 mM concentration of MgCl2. Immediately 
prior to use, all solutions were filtered independently with a 0.2 μm Gelman filter. 
To ensure complete dialysis of the intracellular solution, data was collected at 
least 10 minutes after attaining whole cell configuration. 
 
Conductance-Voltage Relationship for CHO Cell Recordings 
Steady state and kinetic gating parameters were examined through the use of 
standard pulse protocols and solutions described by our lab and others209,216-
218,220-222. Cells were held at -120 mV, stepped to more depolarized potentials     
(-100 mV to +40 mV in 10 mV increments) for 100 ms, and returned to the 
holding potential. Consecutive pulses were stepped every 1.5 s and the data 
were leak subtracted using the P/4 method, stepping negatively from the holding 
potential. Steady state whole cell conductance values (G) were determined by 
measuring the peak current (I) at each test potential (Vp) and predicting a K+ 
Nernst equilibrium potential (Ek= -84 mV) using Ohm’s law (G = I/(Vp – Ek)). The 
maximum conductance generated by each cell was used to normalize the data 
for each cell to its maximum conductance by fitting the data to a single 
Boltzmann distribution (equation 1, solving for maximal conductance). These 
single Boltzmann distributions were used to determine the average Va ± SEM and 
Ka ± SEM values. The normalized data were averaged with those from the other 
cells and the resulting average G-V curve was fit via least squares using the  
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Boltzmann relation below: 
Fraction of maximal conductance = [1 + exp(-(V-Va/Ka))]-1    equation (1) 
where V is the membrane potential, Va is the voltage of half-activation, and Ka is 
the slope factor. 
 
Steady-State Inactivation (hinf) 
Cells were pre-pulsed from -120 mV to +20 mV (10 mV increments) for 1000 ms, 
then stepped to +60 mV for 100 ms, and returned to the holding potential (-120 
mV). The maximum current generated by each cell was used to normalize the 
data for each cell to its maximum current by fitting the data to a single Boltzmann 
distribution (equation 2, solving for maximal current), from which the mean Vi± 
SEM and Ki ± SEM values were determined.   
Fraction of maximal current = [1 + exp-((V-Vi)/Ki)]-1     equation (2) 
where V is the membrane potential, Vi is the voltage of half-inactivation, and Ki is 
the slope factor. 
 
Time Constants of Activation (τn)  
Activation time constants were determined by fitting the current traces used to 
measure the G-V relationships. Whole current traces were fitted using the 
Hodgkin-Huxley function of the PulseFit software suit (HEKA). The current trace 
data were fitted to a fourth power exponential function to determine τn. 
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Recovery from Inactivation 
Cells were held at -120 mV and stepped to +60 mV for 100 ms and subsequently 
returned to the recovery potential for various time intervals (10 – 200 ms in 10 ms 
increments). The potential then was stepped to +60 mV for 100 ms. Peak 
currents measured during the +60 mV depolarizations were compared and the 
fractional peak current that remains during the second depolarization was plotted 
as a function of the recovery pulse duration, representative of the fraction of 
channels recovered from inactivation during the recovery interval. Recovery time 
constants were determined by fitting the data to a single exponential function 
(HEKA). 
 
Cardiomyocyte Potassium Current Recordings 
Potassium currents were collected from neonatal myocytes using the previously 
described recording procedures and equipment. All experiments were performed 
at room temperature using whole cell patch clamp techniques, pulse protocols, 
solutions, and data analyses similar to those described by us and others21,141,218. 
Desialylation or deglycosylation of cardiac myocytes was performed prior to 
recordings through 2 hour treatments at 37ºC with either 0.01 units of sialidase A 
(Neuraminidase; Glykome) or 5 units of PNGase-F (Sigma) in base media218. 
Sialidase A cleaves α2-6, α2-3, and, to a lesser extent, α2-8 and α2-9 sialic acid 
linkages, while PNGase-F removes N-acetylglucosamine at the asparagine 
residue. Myocytes were patched and recorded from in the presence of 
extracellular solution consisting of (mM): 130 NaCl, 5.4 KCl, 1 CaCl2, 1 MgCl2, 
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0.33 Na2HPO4, 10 HEPES, 5.5 glucose (pH 7.4). The intracellular solution was 
(mM): 110 K-Asp, 20 KCl, 8 NaCl, 1 CaCl2, 1 MgCl2, 10 EGTA, 10 HEPES, 4 
K2ATP (pH 7.2)141. Again, all solutions were filtered using 0.2 μm Gelman filters 
prior to use. 9 μM tetrodotoxin (TTX; Tocris Cookson) was added to the filtered 
extracellular solution before data collection to block Nav channels and inhibit 
sodium currents.  
 
Cardiomyocyte Ito and IK,slow G-V Relationships 
Ito and IK,slow were recorded from cardiomyocytes as previously described141,232. IK 
were elicited by holding at -80 mV and initiating 500 ms voltage-clamp steps from 
-110 mV to +50 mV in 10 mV increments. A 100 ms pre-pulse (-60 to -70 mV) 
before the main activation steps was utilized to eliminate any remaining INa (not 
blocked by TTX) and record Ito and IK,slow. IK,slow was isolated by first applying an 
inactivating pre-pulse of -40 mV for 100 ms before the activation steps listed for 
recording IK in order to eliminate Ito and INa. These current traces were then 
subtracted from the total IK traces to isolate Ito. Data analysis was performed 
using PulseFit (HEKA). 
 
Action Potential Recordings from Cardiomyocytes 
Action potentials were recorded at room temperature (~22°C) from myocytes 
using an Axon 200B patch-clamp amplifier with a CV203BU headstage (Axon 
Instruments) and a Nikon TE200 inverted microscope. pClamp 9 software (Axon) 
operating on a Pentium III computer (Dell Computers) was utilized for protocol 
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generation. The extracellular solution was (mM): 135 NaCl, 5 KCl, 2 CaCl2, 1 
MgCl2, 10 HEPES, 10 glucose (pH 7.4). Pipettes were filled with the intracellular 
solution (mM): 110 K-Asp, 20 KCl, 10 NaCl, 4 ATP-Mg, 10 HEPES (pH 7.3)217. 
Removal of glycosylation structures prior to recordings was performed as 
described above. 
 
Action Potential Protocols 
Cells were held at a holding potential of -80 mV. Subsequently, APs were elicited 
using a 2 ms superthreshold depolarizing current at a frequency of 1 Hz from the 
resting membrane potential. Data were analyzed using the Clampfit 9 software 
(Axon Instuments).  
 
Whole Cell Homogenization 
Cells were rinsed with cold PBS and incubated on ice for 5 minutes in cold 
sodium pyrophosphate buffer with protease inhibitors (PI; 20 mmol/liter 
tetrasodium pyrophosphate, 20 mmol/liter Na2PO4, 1 mmol/liter MgCl2, 0.5 
mmol/liter EDTA, 300 mmol/liter sucrose, 0.8 mmol/liter benzamidine, 1 
mmol/liter iodacetamide, 1.1 μmol/liter leupeptin, 0.7 μM pepstatin, 76.8 nM 
aprotinin). Cells were then homogenized using manual tissue grinders. The 
homogenates were centrifuged for 10 minutes at 1000 x g in a Beckman bench-
top centrifuge at 4°C. The supernatant was centrifuged in an Eppendorf 
ultracentrifuge for one hour at 50,000 rpm (4°C) after which, the pellet was 
resuspended in an appropriate volume of sodium pyrophosphate buffer 
containing PIs. The lysates were then stored at -80°C and protein levels were 
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determined using the Pierce BCA Protein Assay kit and a Beckman DU 530 
spectrophotometer218.  
 
Immunoblots  
Immunoblot gel shift analysis was performed as described previously209,220,221. 
Briefly, cell homogenates (2-55 µg/lane) were combined with one volume of 2x 
sample buffer (10% glycerol, 5% 2-mercaptoethanol, 3% sodium dodecyl sulfate, 
and 12.5% upper Tris buffer) and denatured for 3 minutes in boiling water. 
Samples were then run on 6.5% SDS-PAGE gels for 90 minutes at 75-110 mV 
and transferred onto nitrocellulose membranes using a semi-dry transfer cell 
(BioRad). Channel α-subunits were detected through site-directed polyclonal or 
monoclonal antibodies. Monoclonal anti-Kv1.4, anti-Kv2.1, anti-Kv4.2, and anti-
Kv4.3 antibodies were utilized to detect Kv1.4, Kv2.1, Kv4.2 and Kv4.3, 
respectively (1:1000 dilution, NeuroMab).A polyclonal anti-Kv1.5 antibody 
generated against the previously described233 C-terminal human Kv1.5 sequence 
(C)EQGTQSQGPGLDRGVQR was used (1:50 dilution; Biosynthesis, Inc) for 
Kv1.5 detection. After incubation with primary antibody, the blot was treated with 
either goat anti-mouse horseradish peroxidase-conjugated (1:25,000 dilution; 
Jackson) or donkey anti-rabbit horseradish peroxidase-conjugated (1:4500 
dilution; Amersham Biosciences) secondary antibodies and visualized using an 
enhanced chemiluminescence kit (Pierce). Deglycosylation of homogenates was 
performed through 3 hour treatments at 37ºC with 5 units of PNGase-F/10 μg of 
protein (Sigma)218. 
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Click-iT Glycoprotein Labeling and Detection 
Click-iT Glycoprotein Metabolic Labeling Reagents and Detection Kits were 
utilized for these reactions (Invitrogen, Molecular Probes). Cells were transfected 
with channel cDNA as previously described216,220-222. Eight hours post-
transfection, the cells were replated in the presence of the tetraacetylated azido 
sugar of interest at a concentration of 2.5 million cells/100mm dish and incubated 
for 48-72 hours. Tetraacetylated azido-modified sugars were incorporated onto 
protein glycan structures due to the permissive characteristics of oligosaccharide 
synthesis. N-azidoacetylgalactosamine (Ac4GalNAz) was metabolically integrated 
into O-glycosylation structures through the N-acetylgalactosamine salvage 
pathway. N-azidoacetylmannosamine (Ac4ManNAz) was utilized to incorporate a 
modified sugar into the sialic acid biosynthesis pathway. The cells were 
harvested and lysed. Azide-modified glycoprotein samples then were labeled 
with a biotin-alkyne and precipitated185,234-239. The precipitated sample was 
resolubilized and incubated on streptavidin-bound T1 Dynabeads (Invitrogen). 
Because of the strong interaction between streptavidin and biotin, this step 
allows for isolation of only those proteins with the modified sugar incorporated 
into their glycosylation structures. Immunoblot analysis was performed on the 
samples and channels of interest were probed for using channel-specific 
antibodies, as previously described218,220.  
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Cardiac Tissue Isolation 
Neonatal atrial and ventricular samples were isolated for quantitative PCR 
experiments. The animals were euthanized and whole hearts were extracted and 
placed in 0 Ca2+Tyrode’s solution. The atria and ventricles were carefully 
dissected from the heart to ensue only those tissues were removed and the 
remaining portion of the heart was discarded. The tissue was placed in RNAlater 
solution (Qiagen) and incubated at room temperature (~22°C) for a minimum of 
one hour before storage at -80°C. 
 
RNA Isolation and Reverse Transcription 
Cardiac samples from control and ST3Gal-IV(-/-) animals were isolated as 
described above for quantitative PCR experiments. Atrial and ventricular samples 
were composed of 2-6 animals, yielding approximately 10-25 mg of tissue for 
ribonucleic acid (RNA) isolation. Samples were homogenized using douncers 
and RNA was isolated at room temperature (~22°C) according to the RNeasy 
protocol (Qiagen). A Beckman DU 530 Spectrophotometer was used to 
determine the final RNA concentration. 3 µg of RNA were utilized for the reverse 
transcription reaction, which was performed following the SuperScript II Reverse 
Transcriptase protocol (Invitrogen), to yield cDNA for real time reactions.  
 
Quantitative RT-PCR 
Quantitative RT-PCR was performed on 5 Kv α-subunit gene products and one 
constitutively expressed housekeeping gene, 
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hypoxanthinephosphoribosyltransferase (HPRT), as a control. Kv1.5, Kv2.1, 
Kv4.2, Kv4.3, and HPRT primer sets were designed using PrimerQuest (IDT 
DNA), while Kv1.4 primer sets were acquired from a previous study (see 
below)240. The primer sets were run in triplicate for each sample. 25 μl total of 
SYBR Green PCR master mix (Superarray), water, cDNA, and primers were 
added to each well of a 96 well PCR plate (BioRad) and covered with RT-PCR 
optical tape (BioRad). The PCR plate was then centrifuged for 5 minutes at 1000 
rpm and loaded into the Chroma 4 detection system (BioRad). Samples were 
detected using the following protocol: 95°C for 5 min preceding 40 cycles of 95°C 
for 30 seconds, 61°C for 30 seconds, and 30 seconds at 72°C. Relative 
expression levels were determined by the ΔΔCT analysis method. The threshold 
values of a single gene were averaged and compared to the control values 
(HPRT). The resulting ΔCT values are then compared to another sample. Analysis 
was performed using Opticon Monitor (BioRad) and Microsoft Excel. 
 
Quantitative RT-PCR Primer Sequences 
Gene  Forward Primer Reverse Primer 
Kv1.4 CAT TTG GTT TCC CAA TGG TC GTG GTG CAT TCC TTG TTC CT 
Kv1.5 TTC GCA GAG GCA GAC AAT CAG G AGG CAG AGC AAT GGT GAG GA 
Kv2.1 CCC AGT CTC AAC CCA TCC TCA A TGC TGC CCA TCT CCA GTT CT 
Kv4.2 TGA GCG GAG TCT TGG TCA TTG C TGT GCC CTT CGT TTG TCT GC 
Kv4.3 TTT GCC TGG ACA CTG CCT GT CAC ACT GCG GAT GAA GCG GTA T 
HPRT GCA GTA CAG CCC CAA AAT GG GGT CCT TTT CAC CAG CAA GCT 
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Telemetric Electrocardiogram Recordings 
Electrocardiograms were recorded for at least 48 hours on conscious adult (10-
12 week) mice using a Data Exchange Matrix, RPC-1 PhysioTel Receivers, and 
TA10ETA-F20 Implants from DSI. The transmitters were implanted into the 
abdominal cavity of anesthetized animals and the leads sutured to thorax 
muscles in the upper right section and near the apex of the heart. Following 
transmitter implantation, the animals were permitted to recover for one week prior 
to data collection. ECGs were recorded continuously for approximately 48 hours 
and stored on DVDs. Data were analyzed using Data Quest ART and Ponemah 
PNM-P3P-ECG software (DSI). 
 
Data Analysis and Statistics 
Data and statistical analyses were performed using Pulse/PulseFit (HEKA), 
Clampfit (Axon), Data Quest ART, Ponemah PNM-P3P-ECG, Opticon Monitor 
(BioRad), Microsoft Excel, and Sigma Plot (SSPS Inc.). Student’s t-tests were 
performed on the data produced by the electrophysiological recordings. A p-
value of <0.05 was used to determine whether a significant difference exists. 
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CHAPTER 3 
THE SIALYLTRANSFERASE, ST3GAL-IV, ALTERS CARDIAC ACTION 
POTENTIAL WAVEFORMS AND IK 
Precise gating of repolarizing voltage-gated potassium channels is a crucial 
component in producing proper cardiac action potential waveform and duration. 
Alterations in normal Kv channel activity can modify AP repolarization, thereby 
changing its properties, as is observed throughout various physiological and 
pathological processes11,241. Glycosylation is abundant on ion channel proteins, 
including Kv channels157. These attached glycans are generally terminated by 
sialic acid, which have been shown to modulate Kv channel gating through 
isoform-specific mechanisms163,214,216,217.  
 
ST3Gal-IV, a sialyltransferase that adds α2-3 linked sialic acid residues to N- and 
O-linked glycans, is the initiating enzyme for SA addition to a galactose 
moiety242. ST3Gal-IV is expressed at uniform levels throughout cardiac 
development243. One method available to test whether SAs exert an effect on 
cardiac excitability was to utilize a ST3Gal-IV knockout (ST3Gal-IV(-/-)) mouse 
model. Electrocardiograms, AP waveform parameters, and two types of voltage-
gated K+ currents (IK), the transient outward Ito and the slowly inactivating IK,slow, 
were compared in atrial and ventricular myocytes isolated from control and 
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ST3Gal-IV(-/-) animals. A single, previous study conducted by our lab determined 
that loss of the polysialyltransferase, ST8Sia2 (STX), shifts the voltage-
dependence of atrial Nav currents to more positive potentials, slowing the rate of 
AP depolarization and decreasing peak amplitude. Here, we found ST3Gal-IV 
can impact atrial Kv currents and AP duration, thus potentially altering cardiac 
excitability.  
 
Results 
Electrocardiograms suggest slowed heart rates and altered waveforms in 
the ST3Gal-IV(-/-) animal 
To question whether cardiac excitability is impacted by aberrant sialylation that 
results from the loss of a single sialyltransferase, telemetry was utilized to record 
ECGs from conscious, unrestrained adult mice. Telemetry studies, in which a 
radio transmitter is implanted into the abdomen, were performed for 
approximately 48 hours; these extended recording durations should increase the 
probability of observing greater variation in heart rate and any additional 
intermittent conduction problems, if present. One limitation to telemetry is that 
these experiments cannot be conducted in neonatal mice, due to the size of the 
animal relative to the transmitter. However, ST3Gal-IV is uniformly expressed 
throughout cardiac development243; thus, the impact of the loss of this 
sialyltransferase on neonatal cardiac excitability might be echoed in the ECGs 
recorded from adult mice. 
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Figure 3.1. ECGs recorded from conscious, unrestrained control and 
ST3Gal-IV(-/-) mice suggest altered cardiac rhythm in the knockout. 
 
0.1 s
KO1
610 ± 0.54 BPM
KO2
628 ± 0.45 BPM
Control
664 ± 0.38 BPM
RR
P wave
KO1
KO2
Control
A B
C
m
V
m
V
m
V
0.2 s
KO1
KO2
Control  
 
Figure 3.1. A. 1 second sampling of ECGs recorded from two ST3Gal-IV(-/-) mice 
(KO, black and blue) and one littermate control mouse (green). Note the slowed 
heart rate in the KOs compared to the control, B. Enlarged view of two QRS 
segments from two ST3Gal-IV KOs and one littermate control. The P wave and 
the RR segment are lengthened in the KO compared to that of the control.         
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C. Arrhythmias are noted at an increased frequency in the ST3Gal-IV(-/-) mouse. 
Red arrows denote three arrhythmic beats in one ST3Gal-IV(-/-) mouse. Data 
were analyzed using Data Quest ART and Ponemah PNM-P3P-ECG software 
(DSI).  
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ECG data recorded from ST3Gal-IV(-/-) and littermate control mice suggest heart 
rate is slowed in the knockouts relative to the controls (Figure 3.1). However, 
when analyzed further, no significant difference in heart rate was observed 
between knockout and control mice. This likely is attributable to the analysis 
software, which averages the mean heart rate over the approximately 48 hour 
interval.  Additionally, the P waves, indicating atrial depolarization, and R-R 
segments appear to be lengthened in the ST3Gal-IV(-/-) mouse compared to that 
of the littermate control (Figure 3.1). As observed in Figure 3.1, an increase in 
arrhythmic events (lasting for nearly the entire recording duration at inconsistent 
frequencies) has been noted in the knockout animals. Three conditions of 
apparent conduction abnormalities were detected in nearly half of the ST3Gal-IV(-
/-) mice (four of nine). Two of the ST3Gal-IV(-/-) mice exhibited variations in the 
spacing between beats, while one mouse had premature arrhythmic beats 
(Figure 3.1C). Both conduction abnormalities were identified in one knockout 
mouse; no apparent conduction disturbances were detected in the littermate 
controls. Unfortunately, the software available does not have the capabilities to 
allow for more thorough analysis of the data. Although these data cannot firmly 
dictate how the loss of a single sialyltransferase can affect cardiac excitability, 
they do indicate alterations in conduction and rhythm.  
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Action potential duration is prolonged in ST3Gal-IV(-/-) atrial myocytes, yet 
is unaltered in ventricular myocytes 
Action potential duration is a crucial component in the generation of normal 
cardiac conduction and rhythm. In this study, action potentials were elicited from 
control and ST3Gal-IV(-/-) neonatal atrial and ventricular myocytes. Atrial ST3Gal-
IV(-/-) myocytes displayed lengthened repolarization phases, as indicated in 
Figure 3.2. The mean action potential duration (APD) at 10% (APD10), 50% 
(APD50), and 90% (APD90) repolarization was extended significantly in the 
knockout atria (by ~50-80%) compared to the control (Figure 3.2, Table 3.1). The 
time to peak was significantly lengthened in ST3Gal-IV(-/-) atrial myocytes, which 
is associated with the involvement of sodium currents in AP production. 
Furthermore, since repolarization rate is affected dramatically in knockout atrial 
myocytes and Kv currents underlie the AP repolarization phase, these data 
suggest that ST3Gal-IV(-/-) atrial K+ currents may be altered.  
 
To determine the effect of ST3Gal-IV on neonatal ventricular myocyte excitability, 
APs were measured from ST3Gal-IV(-/-) and control ventricular myocytes. Unlike 
that observed for the atria, ventricular APD was not impacted by the absence of 
ST3Gal-IV; APD10, APD50, and APD90 values did not differ significantly between 
control and knockout ventricular myocytes (Figure 3.3). The peak AP voltage and 
the time to peak were unaffected as well. Thus, the data suggest that ST3Gal-IV 
is not required for normal neonatal ventricular AP production (Table 3.1).  
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Figure 3.2. Action potential duration is prolonged in ST3Gal-IV(-/-) atrial 
myocytes. 
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Figure 3.2. A. Trains of action potentials elicited from control (dark blue) and 
ST3Gal-IV(-/-) (light blue) neonatal atrial myocytes. Note the prolongation of the 
ST3Gal-IV(-/-) AP repolarization phase, B. Representative action potential traces 
from control (dark blue) and ST3Gal-IV(-/-) (light blue) atrial myocytes, C, D, & E. 
Bar graphs represent control and ST3Gal-IV(-/-) atrial action potential durations at 
10 % repolarization (C, APD10), 50% repolarization (D, APD50), and 90% 
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repolarization (E, APD90). APD10, APD50, and APD90 are significantly lengthened 
in ST3Gal-IV(-/-)  atrial myocytes compared to control (Table 3.1). Data are Mean 
± SEM. n = 9-10. *=significant compared to control (p<0.005).  
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Figure 3.3. Ventricular action potential duration is not impacted by       
ST3Gal-IV.  
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Figure 3.3. A. Trains of action potentials elicited from control (dark green) and 
ST3Gal-IV(-/-) (light green) neonatal ventricular myocytes, B. Representative 
traces of action potentials recorded from control (dark green) and ST3Gal-IV(-/-) 
(light green) ventricular myocytes, C, D, & E. Bar graphs represent ventricular 
action potential durations at 10 % repolarization (C, APD10), 50% repolarization 
(D, APD50), and 90% repolarization (E, APD90) recorded from control and 
ST3Gal-IV(-/-) ventricular myocytes. APD10, APD50, and APD90 are not significantly 
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altered in ST3Gal-IV(-/-) ventricular myocytes compared to control (p>0.1, Table 
3.1). Data are Mean ± SEM. n = 9-13.  
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Table 3.1. The measured action potential parameters for control and  
ST3Gal-IV(-/-) atria and ventricles. 
 
Cell Type n AP Peak V Time to 
Peak 
APD10 APD50 APD90 
  mV ms ms ms ms 
Control Atria 9 120.1 ± 4.8 3.9 ± 0.1 4.4 ± 0.2 9.0 ± 0.8 22.3 ± 2.6 
ST3Gal-IV(-/-) 
Atria 
10 120.1 ± 6.3 5.0 ± 0.2* 6.6 ± 0.4* 14.2 ± 1.6* 40.1 ± 3.1* 
Control 
Ventricle 
13 138.3 ± 4.3 3.9 ± 0.1 5.7 ± 0.3 21.7 ± 2.5 56.7 ± 6.2 
ST3Gal-IV(-/-) 
Ventricle 
9 147.7 ± 2.9 3.7 ± 0.2 5.5 ± 0.3 18.9 ± 1.3 59.8 ± 5.6 
 
Table 3.1. Data are the mean ± SEM. APD: Action potential duration. 
Significance was determined using a two-tailed Student’s t-test comparing 
ST3Gal-IV(-/-) action potential parameters to control. * = significance (p<0.005). 
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The voltage-dependence of Ito and IK,slow activation is altered in the atria, but 
is unaffected in the ventricles of ST3Gal-IV(-/-) animals 
As previously stated, voltage-gated potassium currents are responsible for the 
repolarization phase of the AP. Since atrial AP duration was prolonged in the 
absence of ST3Gal-IV (Figure 3.2), two Kv currents involved in AP repolarization 
were examined in control and knockout neonatal atrial myocytes. The transient 
portion (Ito) of IK was eliminated by application of an inactivating pre-pulse (-40 
mV, 100 ms) prior to the activation protocol for IK,slow. The remaining current, 
IK,slow, was measured and analyzed (Figures 3.4 and 3.5). Figure 3.4 shows atrial 
IK,slow activates at more depolarized potentials in ST3Gal-IV(-/-) myocytes 
compared to control. The conductance-voltage relationship was shifted by a 
depolarizing ~14 mV in the knockout from that observed for the control. Further, 
the Va of IK,slow measured from ST3Gal-IV(-/-) atrial myocytes was shifted to more 
depolarized potentials compared to control Va. Thus, a stronger depolarization is 
necessary to activate IK,slow in the knockout atria (Figure 3.4, Table 3.2). Ito was 
obtained by subtracting the current traces measured with and without the 
inactivating pre-pulse (IK,slow was subtracted from IK). G-V relationships for Ito 
measured from control and ST3Gal-IV(-/-) atrial myocytes are shown in Figure 3.4. 
Similar to that of IK,slow, the G-V relationships and Va of atrial Ito were shifted to 
more depolarized potentials in knockout myocytes as compared to control; a 
positive shift of ~15 mV was observed for ST3Gal-IV(-/-) atrial Ito (Table 3.2).  
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Figure 3.4. Atrial Ito and IK,slow activation are altered by loss of ST3Gal-IV. 
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Figure 3.4. A. Representative atrial myocyte voltage-gated potassium current (IK) 
traces. IK consists of Ito and IK,slow, which can be separated experimentally,         
B. Representative IK,slow current traces recorded from atrial myocytes,                 
C & D. Steady-state activation of Ito and IK,slow recorded from control (dark blue) 
and ST3Gal-IV(-/-) (light blue) atrial myocytes. Data are the mean normalized 
peak conductance ± SEM and are fit to a single Boltzmann relationship (lines). 
Here and throughout, error bars are smaller than the symbol if not visible. n = 5 – 
7 (Table 3.2), C. G-V relationships for Ito activation (circles). Note the ~15 mV 
shift to more depolarized potentials in the ST3Gal-IV(-/-) myocytes compared to 
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the controls, D. G-V relationships for steady-state activation of IK,slow (squares). A 
~14 mV depolarizing shift in steady-state activation was observed in the ST3Gal-
IV(-/-) atrial myocytes compared to the controls.  
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Although ST3Gal-IV(-/-) ventricular myocytes demonstrated no measureable 
change in APD, ventricular Ito and IK,slow were examined to confirm ventricular K 
currents were not impacted by the absence of this sialyltransferase. As predicted, 
steady-state activation of Ito and IK,slow recorded from ST3Gal-IV(-/-) and control 
ventricular myocytes was not different significantly (Figure 3.5, Table 3.2). 
Therefore, these data suggest that production of normal neonatal ventricular Ito 
and IK,slow was maintained in the absence of ST3Gal-IV. 
 
Discussion 
Changes in normal cardiac conduction may pose serious pathological 
consequences; therefore, the data presented here may provide some insight into 
how excitability is modulated throughout the heart. ECG recordings suggest mice 
deficient in the sialyltransferase ST3Gal-IV demonstrate slower heart rates than 
littermate controls. Parasympathetic input controls the beat-to-beat pacing of the 
heart. Thus, loss of ST3Gal-IV may modulate these inputs, resulting in the 
altered heart rate observed in ST3Gal-IV(-/-) mice. Broadened P waves were 
noted in the knockout as well, suggesting a slowing of atrial conduction 
potentially through alterations in Nav or Kv channel function (Figure 3.1). While 
not entirely quantitative, the data indicate a trend toward altered cardiac 
conduction in the knockout animal, as an increased incidence of arrhythmic 
events was observed. The arrhythmogenic trend noted in the ST3Gal-IV(-/-) 
animals may impact AP production by altering the gating of ion channels, 
including potassium, sodium, or hyperpolarization-activated cyclic nucleotide- 
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Figure 3.5. ST3Gal-IV deficiency does not affect ventricular Ito and IK,slow. 
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Figure 3.5. A. Representative voltage-gated potassium current (IK) traces 
recorded from ventricular myocytes. IK consists of Ito and IK,slow, which can be 
separated experimentally, B. Representative ventricular IK,slow current traces,      
C & D. Steady-state activation of Ito and IK,slow recorded from control (dark green) 
and  ST3Gal-IV(-/-)(light green) ventricular myocytes. No significant shift in steady-
state activation was noted in ST3Gal-IV(-/-) ventricular myocytes compared to 
controls (p>0.1). Data are the mean normalized peak conductance ± SEM and 
are fit to single a Boltzmann relationship (lines). n= 4 (Table 3.2), C. G-V 
relationships for Ito activation (circles), D. G-V relationships for steady-state 
activation of IK,slow (squares). 
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Table 3.2. Measured gating parameters for atrial and ventricular Ito and     
IK,slow from control and ST3Gal-IV(-/-) mice. 
 
Current n Va Ka 
  mV mV 
Control Atrial Ito 7 -34.5 ± 1.7 6.7 ± 0.8 
ST3Gal-IV(-/-) Atrial Ito 5 -19.2 ± 1.2* 8.1 ± 0.9 
Control Atrial IK,slow 7 -40.4 ± 1.3 8.3 ± 0.6 
ST3Gal-IV(-/-) Atrial IK,slow 5 -26.8 ± 2.9* 7.9 ± 0.7 
Control Ventricular Ito 4 -8.9 ± 1.6 13.4 ± 1.0 
ST3Gal-IV(-/-) Ventricular Ito 4 -9.6 ± 2.3  12.1 ± 1.3 
Control Ventricular IK,slow 4 -11.3 ± 1.3 12.7 ± 0.5 
ST3Gal-IV(-/-) Ventricular IK,slow 4 -10.0 ± 2.0  12.8 ± 1.3 
 
Table 3.2. Data are the mean ± SEM. Va: Voltage of half-activation. Ka: 
Boltzmann activation slope factor. Significance was determined using a two-
tailed Student’s t-test comparing ST3Gal-IV(-/-) Ito and IK,slow activation parameters 
to control. * = significance (p<0.005). 
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gated (HCN; pacemaker) channels, by modulating the response of the autonomic 
nervous system, and/or by some other unknown method. Therefore, these data 
only suggest that the absence of ST3Gal-IV can modify cardiac conduction, 
without detailing the mechanism. 
 
To determine whether cellular excitability was modulated by ST3Gal-IV 
expression, atrial and ventricular APs were measured for control and knockout 
myocytes. Action potential durations were lengthened significantly in the ST3Gal-
IV(-/-) neonatal atria compared to control, and yet were unaffected in the ventricle 
(Figures 3.2 and 3.3). Consistently, our lab reported that action potential 
parameters were altered in atrial myocytes, but not ventricular myocytes, lacking 
the sialyltransferase STX. The previous study also found a slower time to peak 
and a reduced peak AP voltage in the STX(-/-) atrial myocytes189, only one of 
which was observed in ST3Gal-IV(-/-) atrial APs (lengthened time to peak). As 
with all transgenic mouse systems, the absence of one enzyme may trigger the 
up-regulation of another with different substrate specificity, leading to variability in 
glycosylation patterns. In vivo, the combination of lengthened atrial APD (likely 
due to changes in potassium channel function) and a possible effect on HCN 
channels and/or the autonomic nervous system may lead to increased frequency 
or severity of irregularities in cardiac conduction and rhythm. Thus, alterations in 
glycosylation likely impact more processes than atrial AP production, as 
discussed further in the Final Discussion. 
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Half-activation voltages of the repolarizing Kv currents, Ito and IK,slow, were shifted 
to more positive potentials in the knockout atria as well; no significant effect of 
the loss of ST3Gal-IV was observed on ventricular Kv currents (Figures 3.4 and 
3.5). These data are consistent with our ECG and AP findings; the lengthened 
atrial APD and time to peak corresponds to the broadened P wave on the ECG, 
which represents atrial depolarization. Additionally, the data presented here are 
consistent with previously published reports from our lab. Rat neonatal 
ventricular sodium channels were shown to be less sialylated than those 
expressed in neonatal atria218. Recently submitted data from our lab suggest Nav 
currents are shifted to more positive potentials in STX(-/-) atrial myocytes189, which 
correlates with the slowed time to peak observed from STX(-/-) and ST3Gal-IV(-/-) 
atrial APs. Aberrant sialylation, through the loss of a single sialyltransferase (in 
this case ST3Gal-IV), differentially impacts neonatal cardiac Kv currents and APs, 
increasing the susceptibility to altered cardiac conduction.  
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CHAPTER 4 
REMOVAL OF GLYCOSYLATION PROLONGS AP DURATION AND 
MODULATES IK 
Kv channel isoforms, like many ion channels, are uniquely and heavily 
glycosylated proteins. N- and O-glycan structures typically are terminated by 
numerous negatively charged sialic acid residues. A previous report showed that 
adult murine ventricular Kv channels responsible for Ito, likely Kv4 channels, 
require a greater depolarization (~11-18 mV) to undergo voltage-dependent 
gating events upon treatment to remove sialic acid; ventricular APD was 
prolonged as well217. Furthermore, the data presented in chapter three show that 
atrial APD and IK were altered by reduced sialylation, produced by a deficiency in 
the sialyltransferase ST3Gal-IV. In addition to Kv channels, gating of cardiac Nav 
channels is impacted by changes in glycosylation57,218. N-glycosylation has also 
been shown to impact the gating of voltage-gated ion channels214,215. 
 
In this chapter, we questioned whether enzymatic removal of specific glycans, 
namely sialic acids and N-glycans, could influence neonatal cardiac Kv currents, 
thus modulating AP repolarization. This will allow for confirmation of the ST3Gal-
IV(-/-) cardiomyocyte data presented in Chapter 3 and determination of whether N-
glycans modulate cardiac K+ currents and APs. Glycosidases to remove sialic 
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acid residues and N-glycosylation structures were utilized (Figure 4.1). Atrial 
APD was prolonged significantly under glycosidase treated conditions compared 
to the untreated control, while no effect on ventricular AP duration was observed. 
Consistent with that seen for the APs, data indicate that a reduction in sialylation 
and N-glycosylation cause a large, depolarizing shift in the voltage dependence 
of activation for Ito and IK,slow in atrial myocytes; however, ventricular Kv currents 
were not affected. N-glycosylation did not exert a supplementary effect on atrial 
Kv currents. Thus, sialylation, but not N-glycosylation, modulates production of 
atrial APs and K+ currents, likely increasing susceptibility to altered cardiac 
rhythm. 
 
Results 
Action potentials are prolonged in neonatal atrial myocytes following 
removal of glycosylation 
Changes in AP waveform and duration can lead to alterations in cardiac 
excitability; therefore, we investigated whether changes in glycosylation (via 
enzymatic removal of glycans) can impact the cardiac action potential. Thus, 
whole cell action potentials were recorded from neonatal atrial myocytes under 
conditions of full and reduced glycosylation. Atrial myocytes incubated with 
neuraminidase prior to recordings, to cleave sialic acid residues, showed 
prolonged repolarization (Figure 4.1). Figure 4.2 summarizes the mean action 
potential duration at 10%, 50%, and 90% repolarization as recorded from 
untreated control and neuraminidase treated neonatal atrial myocytes. Measured 
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Figure 4.1. Enzymatic treatment to remove glycosylation 
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Figure 4.1. Two enzymes were utilized to remove specific glycosylation residues. 
Sialic acids are removed by treatment with the glycosidase neuraminidase. 
PNGase-F cleaves N-glycosylation structures at the asparagine residue. Figure 
modified from Varki, et al, 2009244. 
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Figure 4.2. Glycosidase treatment prolongs atrial action potential duration.  
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Figure 4.2. A. Representative traces of action potentials measured from 
untreated control (blue), Neuraminidase treated to remove sialic acid residues 
(red), and PNGase-F treated to cleave N-glycosylation (pink) atrial myocytes, B, 
C, &D. Action potentials were recorded from untreated control atrial myocytes 
(blue) and following treatment with Neuraminidase (red) or PNGase-F (pink). Bar 
graphs represent action potential duration at 10% (B), 50% (C), and 90% (D) 
repolarization (Table 4.1). Data are the mean ± SEM. n =9-10. *= significant 
compared to control (p<0.005).  
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APDs in the neuraminidase treated myocytes were significantly longer (by ~35-
150%) compared to the untreated control (Table 4.1). Additionally, the peak AP 
voltage (maximal depolarization) and the rate of rise were prolonged in 
neuraminidase treated myocytes.  
 
PNGase-F, an enzyme that removes surface N-glycosylation at the asparagine 
residue, was employed to determine whether N-glycosylation exerts an additional 
effect on neonatal atrial action potential duration (Figure 4.1). APs recorded from 
PNGase-F treated atrial myocytes demonstrated prolonged durations. PNGase-F 
treated atrial APD10, APD50, and APD90 values were ~25-85% greater than 
untreated control (Figure 4.2, Table 4.1). However, no significant effect of 
PNGase-F treatment was observed on peak AP voltage or the time to peak. 
Further, PNGase-F treated atrial AP durations were not significantly different 
than those of the neuraminidase treated myocytes (Table 4.1). 
 
Ventricular action potentials are unaffected by changes in glycosylation 
Action potentials recorded from neonatal ventricular myocytes also were 
examined under conditions of reduced glycosylation. Again, ventricular myocytes 
were treated with either neuraminidase or PNGase-F to remove sialylation or N-
glycosylation, respectively. APDs were not significantly impacted by pre-
incubation with either neuraminidase or PNGase-F. The peak AP voltage and 
rate of rise were unaffected as well, suggesting that glycosylation is not a  
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Figure 4.3. Ventricular action potentials are not affected by removal of 
glycosylation. 
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Figure 4.3. A. Representative action potential traces from untreated control 
(green), Neuraminidase treated to remove sialic acid residues (red), and 
PNGase-F treated to cleave N-glycosylation (purple) ventricular myocytes,        
B, C, & D. Action potential durations measured from untreated control ventricular 
myocytes and following treatment with Neuraminidase or PNGase-F. No 
significant impact on ventricular APD was observed upon treatment with 
glycosidases (p>0.1). Bar graphs represent action potential duration at 10% (B), 
50% (C), and 90% (D) repolarization (Table 4.1). Data are the mean ± SEM.  
n=8-13.  
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Table 4.1. The measured action potential parameters for control and 
glycosidase treated atria and ventricles. 
 
Cell Type n AP Peak V Time to 
Peak 
APD10 APD50 APD90 
  mV ms ms ms ms 
Untreated Control 
Atria 
9 120.1 ± 4.8 3.9 ± 0.1 4.4 ± 0.2 9.0 ± 0.8 22.3 ± 2.6 
Neuraminidase 
Treated Atria 
10 139.8 ± 4.9* 4.5 ± 0.2* 5.9 ± 0.3* 17.4 ± 2.0* 55.1 ± 9.3* 
PNGase-F 
Treated Atria 
9 124.0 ± 11.9 4.5 ± 0.4 5.5 ± 0.4* 13.8 ± 0.9* 41.3 ± 3.0* 
Untreated Control 
Ventricle 
13 138.3 ± 4.3 3.9 ± 0.1 5.7 ± 0.3 21.7 ± 2.5 56.7 ± 6.2 
Neuraminidase 
Treated Ventricle 
9 146.4 ± 2.3 4.3 ± 0.2 6.3 ± 0.4 22.6 ± 2.5 55.0 ± 3.5 
PNGase-F 
Treated Ventricle 
8 136.9 ± 6.4 4.0 ± 0.2 6.3 ± 0.9 22.1 ± 2.2 55.6 ± 2.9 
 
Table 4.1. Data are the mean ± SEM. APD: Action potential duration. 
Significance was determined using a two-tailed Student’s t-test comparing 
Neuraminidase or PNGase-F treated action potential parameters to untreated 
control. * = significance (p<0.02). 
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significant factor in production of neonatal ventricular action potentials (Figure 
4.3, Table 4.1). 
 
Atrial Ito and IK,slow activation is shifted to more depolarized potentials with 
removal of glycosylation  
As previously discussed, voltage-gated potassium currents are responsible for 
AP repolarization. Since atrial AP repolarization was prolonged by removal of 
glycosylation structures, two Kv currents involved in AP repolarization were 
examined under conditions of full and reduced glycosylation. IK,slow and Ito were 
separated experimentally, as described in Chapter 3. Figure 4.4 shows IK,slow 
under conditions of reduced sialylation (neuraminidase treated) activated at more 
depolarized potentials than when fully sialylated. The conductance-voltage 
relationship for IK,slow recorded from neuraminidase treated myocytes was shifted 
to more depolarized potentials from that observed for the untreated control. 
Likewise, the Va was shifted by a depolarizing ~17 mV for neuraminidase treated 
myocytes, indicating a stronger depolarization is required to activate IK,slow in the 
absence of sialic acids (Figure 4.4, Table 4.2). Upon treatment with PNGase-F to 
remove surface N-glycosylation, the G-V relationship and the Va for IK,slow were 
shifted to more depolarized potentials by ~12 mV compared to untreated control. 
These data suggest that N-glycosylation structures do not exert an additional 
effect on atrial IK,slow activation compared to the effect with neuraminidase, 
consistent with that reported for the action potentials (Figure 4.4, Table 4.2).  
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Figure 4.4. Deglycosylation shifts steady-state activation of atrial Ito and 
IK,slow to more depolarized potentials. 
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Figure 4.4. Steady-state activation of Ito and IK,slow as measured from control 
(dark blue), neuraminidase treated (red), and PNGase-F treated (purple) atrial 
myocytes. Data are the mean normalized peak conductance ± SEM and are fit to 
a single Boltzmann relationship (lines). n = 7 – 4 (Table 4.2), A. G-V relationships 
for steady-state activation of Ito (circles). Note the ~9-14 mV shift to more 
depolarized potentials in the glycosidase treated atrial myocytes compared to the 
controls, B. G-V relationships for IK,slow activation (squares). A ~12-17 mV 
depolarizing shift in steady-state activation was observed in the glycosidase 
treated atrial myocytes compared to the controls. 
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Figure 4.4 also shows the plotted G-V relationships for Ito as recorded from atrial 
myocytes ± neuraminidase or PNGase-F treatment. The G-V curve for Ito 
recorded from neuraminidase treated atrial myocytes was shifted to more 
depolarized potentials by a significant ~14 mV; additionally, the Va was shifted in 
the depolarized direction to a similar extent (Figure 4.4, Table 4.2). Treatment of 
atrial myocytes with PNGase-F revealed a depolarizing shift of ~9mV in the Va 
compared to that of untreated control, with the G-V curve shifted accordingly 
(Figure 4.4, Table 4.2). Ito measured from PNGase-F treated atrial myocytes was 
not different significantly from that reported for neuraminidase treated myocytes. 
Again, this is consistent with the AP data presented earlier. 
 
Glycosylation does not impact ventricular Ito or IK,slow activation 
Although there was no observable effect of glycosylation on ventricular AP 
duration and repolarization, Ito and IK,slow were measured in neonatal ventricular 
myocytes under conditions of full and reduced glycosylation to determine 
whether IK was altered. Similarly, a reduction in glycosylation, through 
neuraminidase or PNGase-F treatment, had no significant effect on activation of 
ventricular Ito or IK,slow (Figure 4.5, Table 4.2). The G-V relationships and Va were 
not significantly different in the treated myocytes (with either neuraminidase or 
PNGase-F) compared to untreated controls. These data suggest that 
glycosylation does not play a functional role in neonatal ventricular potassium 
current generation.  
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Figure 4.5. Steady-state activation of ventricular Ito and IK,slow is unaffected 
by treatment with glycosidases. 
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Figure 4.5. Ito and IK,slow steady-state activation recorded from control (green),  
neuraminidase treated (dark red), and PNGase-F treated (purple) ventricular 
myocytes. No significant shift in steady-state activation was noted in 
neuraminidase or PNGase-F treated myocytes compared to controls (p>0.1). 
Data are the mean normalized peak conductance ± SEM and are fit to a single 
Boltzmann relationship (lines). n= 4 – 3 (Table 4.2), A. G-V relationships for Ito 
activation (circles), B. G-V relationships for steady-state activation of IK,slow 
(squares).  
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Table 4.2. Measured gating parameters of atrial and ventricular Ito and IK,slow 
under control and glycosidase treated conditions. 
 
 
Current n Va Ka 
  mV mV 
Control Atrial Ito 7 -34.5 ± 1.7 6.7 ± 0.8 
Neuraminidase Treated Atrial Ito 4 -20.5 ± 0.7* 7.4 ± 0.7 
PNGase-F Treated Atrial Ito 4 -25.4 ± 2.3* 9.7 ± 1.4 
Control Atrial IK,slow 7 -40.4 ± 1.3 8.3 ± 0.6 
Neuraminidase Treated Atrial IK,slow 4 -23.8 ± 1.4* 10.3 ± 0.2* 
PNGase-F Treated Atrial IK,slow 4 -28.8 ± 1.0* 10.6 ±0.4* 
Control Ventricular Ito 4 -8.9 ± 1.6 13.4 ± 1.0 
Neuraminidase Treated Ventricular Ito 4 -10.2 ± 1.3 13.6 ± 1.3 
PNGase-F Treated Ventricular Ito 3 -10.5 ± 1.7 11.9 ± 0.8 
Control Ventricular IK,slow 4 -11.3 ± 1.3 12.7 ± 0.5 
Neuraminidase Treated Ventricular IK,slow 4 -14.1 ± 2.1 13.5 ± 0.4 
PNGase-F Treated Ventricular IK,slow 3 -10.7 ± 2.6 12.1 ±0.6 
 
 
Table 4.2. Data are the mean ± SEM. Va: Voltage of half-activation. Ka: 
Boltzmann activation slope factor. Significance was determined using a two-
tailed Student’s t-test comparing glycosidase (Neuraminidase or PNGase-F) 
treated Ito and IK,slow activation parameters to untreated control. * = significance 
(p<0.005). 
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Discussion 
Atrial action potentials are modulated by alterations in glycosylation, while 
ventricular action potentials are unaffected 
Alterations in action potential duration potentially can impact the rhythmicity of 
the heart; lengthening or shortening of APD has been identified as pro-
arrhythmic245. Therefore, this chapter examined the effects of enzymatic 
glycosylation removal on neonatal cardiac action potentials. As Figure 4.2 
suggests, treatment of atrial myocytes with neuraminidase or PNGase-F 
significantly and similarly lengthened action potential duration at 10%, 50%, and 
90% repolarization. Interestingly, peak AP voltage and time to peak were 
significantly prolonged in neuraminidase treated atrial myocytes, but were 
unaffected with PNGase-F treatment (Table 4.1). As shown in a previous study, 
atrial Nav currents were impacted by loss of the polysialyltransferase ST8Sia2 
(STX)189. Thus, changes in the peak AP voltage and time to peak could be 
caused by alterations in Nav channel gating upon removal of O-linked sialic 
acids, as these would not be removed upon treatment with PNGase-F; 
incomplete removal of N-glycan structures may also be responsible for these 
results (see Final Discussion). In addition, ventricular APD was not impacted 
significantly by removal of sialylation or N-glycan structures; however, a previous 
report by Ufret-Vincenty, et al found that neuraminidase treatment lengthened 
adult murine ventricular APs217. The inconsistent data may be the result of 
increased complex glycan structures in the adult ventricle compared to the 
neonatal ventricle, as supported by data from our lab189,218. Therefore, the results 
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presented here and in chapter 3 suggest that normal glycosylation is an essential 
component in neonatal atrial, but not ventricular, AP production (Figures 4.2 and 
4.3, Table 4.1).  
 
Glycosylation affects cardiac Ito and IK,slow activation in a chamber-specific 
manner 
Here, atrial action potential repolarization was shown to be modulated by 
removal of glycosylation, with all or most of the effect due to sialylation. Since K+ 
channels are responsible for the AP repolarization phase, it was predicted that 
atrial K+ currents were affected as well. In fact, we showed voltage-dependent 
depolarizing shifts of ~14-17 mV in steady-state activation of atrial Ito and IK,slow 
with neuraminidase treatment to remove surface sialic acids (Figure 4.4, Table 
4.2). Removal of N-glycans via PNGase-F treatment shifted atrial Ito and IK,slow 
activation to more depolarized potentials, comparable to those observed with 
neuraminidase treatment (~9-12 mV). Further, we can conclude that N-
glycosylation does not exert an additional effect on atrial Kv channel gating, as 
evidenced by the production of similar Kv currents and APs upon treatment with 
two distinct glycosidases (neuraminidase and PNGase-F). As discussed further 
in chapters five and six, only one Kv channel isoform responsible for Ito 
production is N-glycosylated, Kv1.4; Kv4.2 and Kv4.3 do not contain any 
extracellular N-glycosylation sites. Thus, N-linked sialylation of Kv1.4 may be 
contributing all or most of the effect of glycosylation on Ito activation. However, O-
linked sialic acids attached to Kv1.4, Kv4.2, or Kv4.3 might be responsible for the 
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slightly greater effect observed on Ito measured from neuraminidase treated atrial 
myocytes. The same phenomenon may be occurring for IK,slow as well; O-linked 
sialylation could be contributing an effect on Kv1.5 and Kv2.1 activation.  
 
Ventricular Kv currents displayed no significant effect of changing glycosylation 
levels (Figure 4.5, Table 4.2). Nevertheless, a shift to more depolarized 
potentials was observed for adult ventricular Ito activation with neuraminidase 
treatment in a previous study217. This inconsistency was not unexpected, as it 
has previously been shown that Nav channels are less sialylated in rat neonatal 
ventricular myocytes than neonatal atria or adult atria and ventricle218. Our lab 
recently provided additional evidence supporting this phenomenon (see 
above)189. As seen here, glycosylation impacts the generation of neonatal 
cardiac Kv currents through a chamber-specific mechanism; a significant effect of 
changing glycosylation is observed in the neonatal atria, but not the ventricles. 
Further, the neonatal murine heart rate is slower than that of the adult. 
Physiologically, it may not be essential for neonatal ventricular myocytes to be as 
sialylated as neonatal atrial or adult atrial and ventricular myocytes. As previously 
discussed, sialic acids have been shown to enhance ion channel activation so, 
greater sialylation of adult ventricular myocytes would result in faster conduction 
through the ventricles. In certain glycosylation-related pathologies, the differing 
effects of glycosylation throughout the heart could modulate normal conduction 
and rhythmicity, leading to potentially life-threatening arrhythmias. 
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Thus, we showed that changes in glycosylation, mainly sialylation, modulate 
cardiac K+ channel function and have chamber-specific effects. However, to fully 
appreciate the impact of glycosylation on cardiac excitability, we must 
understand how gating of those channels involved in IK production, and thus AP 
repolarization, is affected by changes in glycosylation. As previously discussed, 
several Kv channel isoforms generate cardiac Ito (Kv1.4, Kv4.2, and Kv4.3) and 
IK,slow (Kv1.5 and Kv2.1). The following two chapters detail the results of altered 
glycosylation on Kv1.4 and Kv1.5 (Chapter 5) and Kv2.1, Kv4.2, and Kv4.3 
(Chapter 6) gating. Discussion of the effect of glycosylation/sialylation on gating 
of Kv channel isoforms was divided into two chapters based on the channel 
subfamily and the type of glycosylation attached to each channel (N- or O-
glycosylation).  
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CHAPTER 5 
UNIQUE MODULATION OF Kv1.4 AND Kv1.5 GATING BY N-GLYCANS 
The voltage-gated potassium channel family is comprised of a large and diverse 
set of ion channels that serve a variety of functions throughout the body246,247. 
Various sets of Kv channel isoforms are responsible for the repolarization phase 
of skeletal muscle, neuronal, and cardiomyocyte action potentials75.Slight 
changes in the type, relative density, or activity of Kv channel isoforms that occur 
following a remodeling process can lead to altered action potential repolarization. 
Such remodeling is observed through physiological processes such as 
development and aging, as well as through pathologies such as Long QT 
Syndrome, deafness, and epilepsy58,59,61,64. 
 
 Posttranslational modifications make up a significant portion of the mass of ion 
channels, with glycosylation contributing upwards of 30% of a channel’s total 
mass157. Analyses of samples purified from brain suggested that over 100 sialic 
acid residues per functional molecule are attached to Na+ channel160,164 and 
some Shaker K+ channel proteins154. Previous studies showed that N-glycans 
can modulate Nav and Kv channel activity through isoform-specific 
mechanisms214,220,248. All reported data suggest that sialic acids contribute to the 
full effect of glycans on Nav channel gating through electrostatic 
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mechanisms209,220-222. On the other hand, previous studies indicated that gating 
of Shaker Kv channel isoforms, Kv1.1163,214, Kv1.2249, and the Drosophila ShB 
channel216, were modulated by N-glycans and/or sialic acids through multiple 
mechanisms that include electrostatic mechanisms (surface potential theory) and 
glycan-dependent effects on the stability of channel proteins among functional 
states (gating stabilizing theory).       
 
Here, we questioned whether N-glycans and sialic acids alter the gating of two 
homologous Shaker K+ channel isoforms responsible in part for cardiac IK, Kv1.4 
and Kv1.5. These two isoforms share a great deal of sequence homology, 
including a similar location for the sole N-glycosylation site positioned on the S1-
S2 linkers (Figure 5.1). The data indicate that a reduction in sialylation caused a 
large, depolarizing shift in the voltage-dependence of activation for Kv1.5, while 
Kv1.4 gating was unaffected. Unlike previous studies of Shaker Kv channel 
isoforms214,216,250, N-glycosylation did not exert an additional effect on the gating 
of either isoform. Further, sialic acids modulated Kv1.5 gating solely through 
electrostatic mechanisms. 
 
Results 
Cell lines of Chinese Hamster Ovary cells were utilized to test whether and how 
differential glycosylation impacts gating of two homologous Kv1 isoforms; Pro5 
cells are fully sialylating, while Lec2 cells are essentially non-sialylating due to a 
deficiency in the CMP-sialic acid transporter226. This deficit serves as a model for  
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Figure 5.1. Kv1.4 and Kv1.5 contain one putative N-glycosylation site.  
 
N C
NXS/T
S1                                                                                                                            S2
hKv1.4     ETLPEFR  ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ DDRDLVMALSAGGHGGLLNDTSAPHLENSGHTIFNDPF
hKv1.5     ETLPEFR DERE‐ ‐ ‐ ‐ LLRHPPAPHQP ‐ ‐ ‐ ‐ ‐ ‐ ‐PAPAPGANGSGVMAPPSGPTVAPLLPRTLADPF
 
 
Figure 5.1.Schematic of a Kv1 channel α-subunit. The amino acid sequences of 
the S1-S2 linker for human Kv1.4 and Kv1.5 are shown above. The N-
glycosylation consensus sequences are underlined in red and conserved 
sequences are shown in black. 
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one form of Congenital Disorders of Glycosylation, CDG type-IIf,192 and was used 
by several investigators, including our laboratory, to question how sialic acids 
modulate ion channel gating163,214,216,217,220,221. We predicted that Kv1.4 and Kv1.5 
gating would be similarly impacted by the N-glycans attached to the homologous 
positions along the channel structure. However, the data indicate unique and 
different effects of N-glycans on Kv1.4 and Kv1.5 gating.   
 
N-linked sialic acids account for the full effect of glycans on Kv1.5 gating 
N-linked glycans impact Kv1.5 gating 
Kv1.5 is partially responsible for the production of a slowly inactivating current 
(IK,slow) involved in action potential repolarization in cardiomyocytes and 
neurons251-253. The data presented in chapters three and four suggest that 
changes in glycosylation, most notably sialylation, shift the voltage-dependence 
of atrial IK,slow activation to more depolarized potentials, effectively lengthening 
AP repolarization and duration. To determine whether N-glycosylation impacts 
Kv1.5 gating, a Kv1.5 N-glycosylation mutant (Kv1.5N290Q) was generated by 
mutating the asparagine residue (N) that initiates the potential N-glycosylation 
consensus sequence to a glutamine (Q). Kv1.5N290Q expressed currents similar to 
that produced by the wild-type channel. However, the conductance-voltage 
relationship for Kv1.5N290Q was shifted along the voltage axis by a depolarizing 
~18 mV compared to the wild-type Kv1.5 G-V relationship, suggesting that N-
glycosylation modulates Kv1.5 channel activation (Figure 5.2B, Table 5.1). To 
confirm that lack of N-glycosylation caused by the N to Q mutation was 
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responsible fully for the observed effect on channel gating, the serine (S) residue 
of the N-glycosylation site was mutated to an alanine (A) in order to generate a 
second N-glycosylation mutant Kv1.5 channel (Kv1.5S292A). The G-V relationship 
and the half-activation voltage for the Kv1.5S292A channel were not significantly 
different from that measured for the Kv1.5N290Qchannel (Figure 5.2B, Table 5.1). 
These data indicate that mutation of the asparagine residue or the serine residue 
that comprise the N-glycosylation consensus sequence impacted channel gating 
identically, allowing one to infer that the mutation itself did not significantly 
influence Kv1.5 gating, but rather the lack of N-glycosylation was responsible for 
modulated Kv1.5 gating. The data indicate that N-glycosylation promotes 
activation of Kv1.5 by causing a significant shift in the voltage at which the 
channel activates.  
 
N-linked sialic acids account for the full effect of sugars on Kv1.5 gating 
To determine whether Kv1.5 sialic acids contribute to the effect of N-glycans on 
channel gating, Kv1.5 activation was studied under conditions of full and reduced 
sialylation by expressing the channel in Pro5 (full sialylation) and Lec2 (reduced 
sialylation) cell lines. As shown in Figure 5.2, Kv1.5 under conditions of reduced 
sialylation activated at more depolarized potentials than the fully sialylated 
channel. The G-V relationship for the less sialylated Kv1.5 was shifted by a 
depolarizing ~18 mV from that observed for the fully sialylated channel. Likewise, 
the Va was shifted to more depolarized potentials for the less sialylated channel, 
indicating a stronger depolarization is required to activate Kv1.5 in the absence of  
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Figure 5.2. N-linked sialic acids account for the full effect of glycans on 
Kv1.5 activation.        
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Figure 5.2. A. Typical Kv1.5 + SA (Pro5) whole cell current traces. SA: Sialic acid.          
B & C. Voltage-dependence of Kv1.5 ± SA, Kv1.5N290Q ± SA and Kv1.5S292A + SA 
activation, B. Conductance-voltage (G-V) relationships. Data are the mean 
normalized peak conductance ± SEM and are fit to a single Boltzmann 
relationship (lines). Black Circles: Kv1.5 + SA; Gray Squares: Kv1.5 – SA; Black 
Upright Triangles: Kv1.5N290Q + SA; Gray Inverted Triangles: Kv1.5N290Q – SA; 
Black Diamonds: Kv1.5S292A + SA. n = 3-11. (Table 5.1), C. Activation time 
constants (τn).  Data are mean ± SEM. Lines are non-theoretical point to point. 
Symbols are as listed in panel B. Inset: Typical current traces measured during a 
0 mV test potential. Peak currents were normalized for comparison. The scaling 
factors used to normalize the currents were 2.63 to 23.75. Solid Black: Kv1.5 + 
SA; Solid Gray: Kv1.5 – SA; Dotted Black: Kv1.5N290Q + SA; Dotted Gray: Kv-
1.5N290Q – SA; Dashed Black: Kv1.5S292A + SA. n = 3-11. 
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sialic acids (Figure 5.2B, Table 5.1). As described, the glycosylation-deficient 
mutant channels, Kv1.5N290Q and Kv1.5S292A, activated at potentials ~18 mV more 
depolarized than fully sialylated Kv1.5, with the corresponding G-V relationships 
nearly identical to Kv1.5 under conditions of reduced sialylation. Further, the G-V 
curve for Kv1.5N290Q was not altered when studied under conditions of reduced 
sialylation and was nearly identical to the G-V curves measured for Kv1.5 under 
conditions of reduced sialylation (Figure 5.2B).Together, these data indicate that 
N-linked sialic acids fully account for the effect of N-glycans on Kv1.5 gating – a 
novel finding among Shaker family Kv channel isoforms.     
 
Sialic acids similarly modulated Kv1.5 activation rate, with channels activating 
more slowly under conditions of reduced sialylation (Figure 5.2C). Note the time 
constants of activation were shifted along the voltage axis by approximately 18 
mV, consistent with the magnitude of the shift in Va observed (Figure 5.2). The 
activation rates for the Kv1.5N290Q and Kv1.5S292A mutant channels when studied 
under conditions of full or reduced sialylation were nearly identical and did not 
significantly deviate from the activation rates for Kv1.5 under conditions of 
reduced sialylation (Figure 5.2C). Thus, the data indicate that sialic acids impact 
Kv1.5 gating, causing the channel to activate at more hyperpolarized potentials; 
this will effectively increase the activity of Kv1.5 at a given membrane potential.   
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Table 5.1. Gating parameters measured for Kv1.5. 
 
Construct n Va Ka 
  mV mV 
Kv1.5 + SA 11 -27.1 ± 3.1 9.3 ± 0.7 
Kv1.5 – SA 11 -8.9 ± 1.8* 10.4 ± 0.3# 
Kv1.5N290Q + SA 5 -7.9 ± 3.0* 8.3 ± 0.3# 
Kv1.5N290Q – SA 4 -8.9 ± 2.6* 9.5 ± 0.5# 
Kv1.5S292A + SA 4 -7.1 ± 1.5* 9.8 ± 0.4# 
 
Table 5.1. Data are mean ± SEM. Va: Voltage of half-activation. Ka: Boltzmann 
activation slope factor. Significance was tested using a two-tailed Student’s t-test 
to compare gating parameters as expressed under conditions of reduced 
glycosylation with control conditions.*= significance (p<0.0005). # = not 
significantly different from control (p>0.1). 
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Figure 5.3. Kv1.5 is N-glycosylated.  
 
 
 
 
Figure 5.3. Immunoblot of Kv1.5 and Kv1.5N290Q. Samples were fractionated on a 
6.5% SDS gel and probed with an anti-Kv1.5 polyclonal antibody directed against 
a C-terminal sequence (1:50 dilution, see Materials and Methods). Lane 1: 
Molecular weight markers, Lane 2: wild-type Kv1.5, Lane 3: Kv1.5N290Q. Protein 
loaded per lane: wild-type Kv1.5, 55 μg; Kv1.5N290Q, 50 μg. 
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Kv1.5 is N-glycosylated 
Immunoblot analysis verified that Kv1.5 expressed in CHO cells is N-glycosylated 
(Figure 5.3). Note a band of lower predicted molecular weight (MW) for the 
mutant Kv1.5N290Q channels compared to the band observed for wild-type Kv1.5.    
 
Kv1.5 sialic acids apparently modulate channel gating by contributing to the 
external negative surface potential 
Negatively charged sialic acids are typically the terminal residue attached to 
external glycans254. These negative charges may contribute to the external 
surface potential that impacts channel gating, as outlined in the surface potential 
theory212. If so, the fully sialylated channel should activate at more 
hyperpolarized potentials than the less sialylated channel, as observed for Kv1.5. 
Further, the presence of external divalent cations would screen the surface 
potential and reduce the impact of the negatively charged sialic acid residues on 
the voltage-dependence of channel gating212,213. Here, the G-V relationships for 
Kv1.5 expressed in Pro5 and Lec2 cells were studied at two different external 
divalent cation concentrations (Figure 5.4A and C). The data show that Kv1.5 
under fully sialylating conditions (in Pro5 cells) was sensitive to changes in 
extracellular divalent cations; the G-V relationship at the lower [divalent cationo] 
shifted by a hyperpolarizing ~13 mV (Figure 5.4A). Changes in [divalent cationo] 
had no significant effect on Kv1.5 gating when expressed in the non-sialylating 
(Lec2) cell line (Figure 5.4C). Extracellular divalent cations similarly modulated 
Kv1.5 activation rate, with fully sialylated channels activating more rapidly under  
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Figure 5.4. Sialic acids modulate Kv1.5 gating through apparent 
electrostatic mechanisms.  
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Figure 5.4. Kv1.5 expressed under conditions of full and reduced sialylation at 3 
mM (normal, filled symbols) and 0.3 mM (low, open symbols) external divalent 
cation concentrations (see Materials and Methods). Black Circles: Kv1.5 + SA; 
Gray Squares: Kv1.5 – SA. n = 3-4, A & C. Conductance-voltage (G-V) 
relationships of Kv1.5 expressed in fully sialylating (Pro5, A) and reduced 
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sialylating (Lec2, C) cells at normal and low external divalent cation 
concentrations. Data are the mean normalized peak conductance ± SEM and are 
fit to a single Boltzmann relationship (lines). ΔVa: Change in the voltage of half-
activation under each condition, B & D. Activation time constants (τn) for Kv1.5 in 
the presence (Pro5, B) and absence (Lec2, D) of sialylation in the presence of 
normal and low external divalent cation concentrations. Data are mean ± SEM. 
Lines are non-theoretical point to point. Insets: Current traces measured during a 
-20 mV test pulse. Peak currents were normalized for comparison. The scaling 
factors used to normalize the currents were 1.02 to 1.13. Solid: normal [divalent 
cationo]; Dotted: low [divalent cationo]. 
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conditions of reduced extracellular [divalent cationo] (Figure 5.4B). No significant 
effect of changing external divalent cation concentration was observed for Kv1.5 
activation when expressed in the non-sialylating cell line (Figure 5.4D). These 
data suggest that N-linked Kv1.5 sialic acids contribute to the external negative 
surface potential and thereby increase Kv1.5 activity through electrostatic 
mechanisms.   
 
Kv1.4 gating is not modulated by N-glycosylation or sialylation 
Sialic acids do not affect Kv1.4 gating 
Kv1.4 is an A-type Kv channel involved in action potential repolarization (in the 
heart, it is responsible for production of Ito,s) and is expressed in many regions of 
the brain and heart255-259. Figure 5.5A shows the normalized, average G-V 
relationships for Kv1.4 expressed in Pro5 and Lec2 cells. Note that the G-V 
relationships and the Va for Kv1.4 under conditions of full and reduced sialylation 
were nearly identical (Figure 5.5A, Table 5.2). The activation data were fit to a 
single Boltzmann relation in Figure 5.5A, but the fit is not ideal, indicating multiple 
gating states. A double Boltzmann relation was utilized as well; however, the fit 
nearly was identical to that of the single Boltzmann. Further, there was no 
significant difference in the voltage dependence of steady-state inactivation for 
Kv1.4 as expressed in Pro5 and Lec2 cells (Figure 5.5B). Therefore, sialylation 
(in CHO cells) does not alter Kv1.4 channel gating. 
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Figure 5.5. Kv1.4 gating is not impacted by sialylation or N-glycosylation. 
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Figure 5.5. A. Typical Kv1.4 whole cell current traces as expressed in Pro5 cells. 
B & C. Voltage-dependence of Kv1.4 ± SA and Kv1.4N354Q + SA. B. G-V 
relationships. Data are the mean normalized peak conductance ± SEM and are 
fit to a single Boltzmann relationship (lines). Black Circles: Kv1.4 + SA (Pro5); 
Gray Squares: Kv1.4 – SA (Lec2); Black Upright Triangles: Kv1.4N354Q + SA.        
n = 3-7. C. Steady-state channel availability (inactivation). Data are the mean 
normalized peak current ± SEM measured during a 100 ms pulse to +60 mV, 
following a 1000 ms pre-pulse to the plotted potentials. Curves are single 
Boltzmann distribution fits to the data. Symbols as listed in panel B. Inset: Kv1.4 
inactivation (hinf) current traces. n = 3-7. (Table 5.2). 
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Table 5.2. The measured gating parameters for Kv1.4. 
 
Construct n Va Ka Vi Ki 
  mV mV mV mV 
Kv1.4 + SA 6 -29.3 ± 2.8 14.6 ± 0.8 -53.6 ± 1.1 -4.0 ± 0.5 
Kv1.4 – SA 7 -26.3 ± 1.4 15.3 ± 0.8 -52.5 ± 1.6 -4.3 ± 0.9 
Kv1.4N354Q + SA 3 -28.4 ± 3.5 15.2 ± 1.3 -52.7 ± 0.3 -4.7 ± 0.1 
 
Table 5.2. Data are mean ± SEM. Va: Voltage of half-activation. Ka: Boltzmann 
activation slope factor. Vi: Voltage of half-inactivation. Ki: Boltzmann inactivation 
slope factor. Significance was tested using a two-tailed Student’s t-test to 
compare gating parameters as expressed under conditions of reduced 
glycosylation with control conditions. No parameter was significantly different 
from control (p>0.05). 
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N-glycosylation does not alter gating of Kv1.4 
Like most Kv1 channels, Kv1.4 contains an N-glycosylation consensus sequence 
on its S1-S2 linker260. To determine whether N-glycans other than sialic acids 
modulate Kv1.4 gating, a mutant Kv1.4 (Kv1.4 N354Q) was generated by replacing 
the asparagine residue (N) of the N-glycosylation consensus site with a 
glutamine residue (Q). Kv1.4 N354Q produced currents similar to those of the wild-
type channel. Gating of the wild-type Kv1.4 and the mutant Kv1.4 N354Q were 
nearly identical, with no significant difference observed for steady-state activation 
or inactivation (Figure 5.5, Table 5.2). It is of interest to note that the Kv1.4N354Q 
activation data did not fit well to either a single or double Boltzmann relation, 
similar to that of the wild-type channel. The N-glycosylation mutant does not 
likely comprise a heterogenous population, eliminating the possibility that a 
differentially glycosylated collection of channels is responsible for the unusual fit 
of the data. Thus, neither N-glycans nor sialic acids modulate Kv1.4 gating.  
 
Kv1.4 is N-glycosylated and sialylated 
To determine whether Kv1.4 expressed in CHO cells is N-glycosylated and 
sialylated, immunoblot gel shift analysis under varying conditions of glycosylation 
was performed (Figure 5.6). Note that only a single band of lower MW was 
detected for the mutant Kv1.4 N354Q lysate compared to the double banding 
pattern observed for the Kv1.4 Pro5 and Lec2 lysates. The lower band of the 
Kv1.4 lysate, presumably a lesser glycosylated (possibly, non-glycosylated) 
Kv1.4, is of similar MW to the non-glycosylated Kv1.4 N354Q mutant channel. The  
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Figure 5.6. Kv1.4 is N-glycosylated and sialylated. 
 
 
 
Figure 5.6. Immunoblot of Kv1.4 and Kv1.4N354Q. Samples were fractionated on a 
6.5% SDS gel and probed with an anti-Kv1.4 monoclonal antibody (1:1000 
dilution, see methods). Lane 1: Molecular weight markers, Lane 2: Kv1.4N354Q, 
Lane 3: Kv1.4 + SA (Pro5), Lane 4: Kv1.4 – SA (Lec2). Protein loaded per lane: 
Kv1.4N354Q, 15 μg; Kv1.4 + SA, 20 μg; Kv1.4 – SA, 2 μg. 
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Kv1.4 lysate as expressed in the non-sialylating Lec2 cell line showed two bands, 
one that matched the lower MW of the wild type Kv1.4 and one that was of lower 
MW than the upper band observed for the Pro5 Kv1.4 lysate. Together, these 
data indicate that Kv1.4 expressed in CHO cells is N-glycosylated and sialylated.   
 
Discussion 
As indicated in Figure 5.1, Kv1.4 and Kv1.5 each contain an N-glycosylation 
consensus site along the S1-S2 linker261. Alignment of Kv1.4 and Kv1.5 S1-S2  
linkers indicate that the Kv1.5 N-glycosylation site is located six amino acids C-
terminal to the location of the Kv1.4 N-glycosylation site. Figures 5.3 and 5.6 
confirm that Kv1.4 and Kv1.5 are N-glycosylated. Here, we show that N-
glycosylation of two Kv1 subfamily members, Kv1.4 and Kv1.5, differently and 
uniquely (for Shaker family Kv channels) modulate channel function.  
 
N-linked sialic acids account for the full effect of glycosylation on Kv1.5 
gating – a novel finding for modulation of Shaker potassium channel 
function 
Sialic acids have a large impact on Kv1.5 gating. The G-V relationship and the Va 
for Kv1.5 were shifted by an identical ~18 mV under conditions of reduced 
sialylation and with removal of N-glycans (Figure 5.2B, Table 5.1). This ~18 mV 
shift in voltage dependence of channel activation is the largest effect of N-
glycans on a Kv1 isoform reported to date. The time constants of activation were 
shifted in the same manner as the G-V relationships and were nearly identical for 
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Kv1.5 under conditions of reduced sialylation and the non-glycosylated mutant 
channels, suggesting that sialic acids modulate Kv1.5 gating through electrostatic 
interactions (Figure 5.2C). This was confirmed by the charge screening 
experiment outlined in Figure 5.4. These data indicate that the full effect of 
glycans on Kv1.5 gating is imposed by N-linked sialic acids.  
 
The surface potential theory predicts that the electric field experienced by the 
voltage sensor(s) of ion channels is altered by external negative charges that 
contribute to a surface potential. External divalent cations act to screen these 
negative charges, effectively neutralizing their impact on the voltage sensed by 
the channel gating mechanism. Thus, a greater depolarization is required to 
activate the channel, producing a positive shift in the Va. Assuming a 
homogenous electric field, changes in the external surface potential should 
impact all voltage-dependent gating parameters equally and shift the G-V curve 
without impacting the slope of the curve212, as observed here for Kv1.5 (Figures 
5.4A and 5.4C). In addition to an impact on surface potential, previous reports 
suggested that glycosylation can alter state stability214,216. The gating stabilizing 
theory, summarized by Hille, et al75, predicts a change in G-V relationship slope 
for any change in state stability, as reported previously by Watanabe, et al214. 
Such an effect was not observed in this study. The G-V slope factor (Ka) 
measured for the two non-glycosylated mutant channels and Kv1.5 expressed 
under conditions of reduced sialylation were not significantly different than the Ka 
measured for Kv1.5 (Figure 5.2B). Further, the activation time constants for the 
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Kv1.5 N-glycosylation mutants also were not significantly different from that of 
Kv1.5 under conditions of reduced sialylation (Figure 5.2C). Therefore, the effect 
of sialic acids on Kv1.5 channel activation is achieved solely through electrostatic 
mechanisms (surface potential theory). The data do not support an additional 
mechanism by which sialic acids or other N-glycans contribute to Kv1.5 gating 
(gating stabilizing theory).This finding is unique among Shaker-like potassium 
channel isoforms. Previous studies of the Drosophila Shaker K+ channel, ShB, 
and the mammalian Kv1.1 and Kv1.2 channels reported additional effects of N-
glycans and/or sialic acids on Kv1 channel function, consistent with a contribution 
of N-glycans to channel state stability163,214,216. The data shown here provide the 
first evidence that gating of a Shaker family potassium channel isoform, Kv1.5, is 
modulated by N-linked sialic acids acting through an electrostatic mechanism 
that is responsible for the full effect of glycans on Kv1.5 gating.    
 
N-glycosylation does not affect Kv1.4 voltage-dependent gating  
In this study, reduced Kv1.4 glycosylation, achieved through a reduction in 
channel sialylation or mutagenesis to remove the full N-glycan structure, had no 
effect on Kv1.4 gating (Figure 5.5). Interestingly, a previous study by Johnson 
and Bennett examined the impact of sialylation and N-glycosylation on a similar 
channel, ShB216. Kv1.4 and ShB are the only two Shaker family K+ channel 
isoforms that undergo N-type inactivation. Both are N-glycosylated, but ShB has 
two potential N-glycosylation sites located within the S1-S2 linker, while Kv1.4 
has only one site262,263. Unlike Kv1.4, a reduction in ShB sialylation resulted in 
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depolarizing shifts in steady-state and kinetic activation and inactivation of ShB. 
Further, N-linked sugars other than sialic acids were shown to exert an 
additional, state stabilizing, effect on channel gating 216.The distinct effects of N-
glycans on Kv1.4 and ShB gating may be due to the number and location of 
putative N-glycosylation sites. That is, 1) The presence of two N-glycosylation 
sites on the ShB S1-S2 linker may vary the position of the glycans and glycan 
structures relative to the voltage sensor and/or 2) Two glycan structures per 
subunit could lead to a mature K+ channel that is potentially twice as sialylated. 
Both possible outcomes could lead to a greater effect of N-glycans on channel 
gating. Further, the ShB S1-S2 linker is significantly shorter than are any of the 
mammalian Kv1 isoforms, and the ShB N-glycosylation sites are located near the 
middle of the linker. The Kv1.4 N-glycosylation site can be found closer to the S2 
transmembrane segment (Figure 5.1). These slight alterations in linker length 
and position of the N-glycosylation site(s) may account for the differing effects of 
glycosylation on rapidly inactivating Shaker family channel gating. Additionally, 
the report published by Johnson and Bennett did not distinguish the individual 
effects of the two N-glycosylation sites, as one may contribute all or most of the 
effect.  
 
Summary 
Together, these data demonstrate that members of the Kv1 channel subfamily 
are affected by glycosylation through distinct mechanisms. The unique effects of 
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glycans on Kv1 family isoforms are relevant to changes in AP repolarization that 
occur with regulated expression and glycosylation of each Kv1 isoform.  
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CHAPTER 6 
O-LINKED SIALIC ACIDS IMPACT Kv CHANNEL GATING 
Precise gating of Kv channels is a crucial component in producing proper 
neuronal, cardiac, and skeletal muscle action potential waveform and duration. 
Ion channel activity can be modulated by varying types and levels of post-
translational modifications, including glycosylation. The number and location of 
glycosylation sites vary among channel types and between isoforms within a 
channel subfamily, including the Kv channel family. Glycans are attached to 
channel proteins putatively through N- and O-linked glycosylation168,175. Several 
studies, including chapter five, detailed the isoform-specific effects of N-glycans 
on Kv163,214-216,264 and Nav209,220,221 channel function. Such studies were possible 
because an external consensus site for N-glycosylation has been identified. 
 
On the other hand, little is known about the role of O-glycosylation on voltage-
gated ion channel activity. The enzymes regulating O-glycosylation are complex, 
and O-glycosylation does not have a recognized consensus sequence187. The 
most prevalent form of O-glycosylation is the mucin-type, in which an N-
acetylgalactosamine is bound to hydroxyl groups of serine or threonine side 
chains175,184. Lectin binding studies, utilizing the lectin Helix pomatia agglutinin to 
bind GalNAc, can identify O-glycosylation structures, but require extensive prior 
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digestion with numerous glycosidases and are, therefore, inefficient265,266. 
However, Cu(I)-catalyzed cycloaddition (Click) chemistry was employed to 
identify the appearance and presence of O-glycosylation during zebrafish 
development 236. 
 
All previous efforts to study the impact of glycosylation on Kv channel function 
concentrated on determining effects of generic glycosylation or N-glycosylation, 
including chapter five of this report163,214-217,264. No previous studies questioned 
the role of O-glycans in Kv channel function.  
 
Kv4.2 and Kv4.3 are members of the Shal subfamily of Kv channels and are 
rapidly activating and inactivating (A-type) channels that produce cardiac Ito,f75. 
Activation of atrial Ito was shifted to more depolarized potentials with reduced 
glycosylation, as discussed in chapters three and four. The putative external 
sequences of Kv4.2 and Kv4.3 do not contain potential N-glycosylation sites. 
Therefore, neither isoform can be N-glycosylated. Kv2.1 is a delayed rectifier that 
contributes to the generation of cardiac IK,slow (see Chapters 3 and 4 for further 
details on the impact of glycosylation on IK,slow). Kv2.1 contains one N-
glycosylation site, located on the S3-S4 linker. Based on recent structural 
models, this site may be inaccessible to the glycosylation machinery of the cell; 
consistently, brain Kv2.1 was shown to not be N-glycosylated84,85,211.  
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In this study, we investigated whether and how sialic acids modulate gating of 
Kv2.1, Kv4.2, and Kv4.3, and probed for the presence of O-glycosylation and 
sialylation. The data show that each isoform is uniquely modulated by sialic acid 
residues that are attached to the channel through O-linkages.  
 
Results 
Negatively charged sialic acids (at physiological pH) are typically located as 
terminal residues on N- and O-glycans, and were shown to impact gating of 
various voltage-gated ion channels differentially163,209,214-217,220,221,264. However, 
all previous studies concentrated on the effect of generic or N-linked sugars on 
ion channel gating without examining the possible specific effects of O-glycans 
on channel function. Unlike N-glycosylation, there is no known consensus 
sequence for O-glycosylation; however, predictive software (OGPET v1.0) and 
the Kv channel crystal structure can be utilized to estimate the location and 
number of possible O-glycosylation sites.  
 
Several Kv isoforms, including Kv2.1, Kv4.2, and Kv4.3, are not likely N-
glycosylated or do not contain N-glycosylation consensus sequences; however, 
potential O-glycosylation site(s) can be identified on and limited to the Kv4.3 S1-
S2 linker and the S5-S6 linker for Kv2.1, Kv4.2, and Kv4.3. These three isoforms 
were expressed in CHO cell lines differing in their ability to sialylate (see 
Materials and Methods and Chapter 5 Results). Kv channel O-glycosylation and 
sialylation were confirmed using Click chemistry. The data indicate for the first  
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Figure 6.1. Sialic acids modulate Kv4.2 and Kv4.3 activation. 
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Figure 6.1. Conductance-voltage (G-V) relationships for Kv4.2 and Kv4.3 under 
conditions of full (Pro5) and reduced sialylation (Lec2). Data are the mean 
normalized peak conductance ± SEM and are fit to a single Boltzmann 
relationship (lines). Insets: Typical whole cell Kv4.2 and Kv4.3 current traces.   
SA: Sialic acid, A. Kv4.2. Black Circles: Kv4.2 + SA; Gray Circles: Kv4.2 – SA.     
n = 8-11, B. Kv4.3. Black Squares: Kv4.3 + SA; Gray Squares: Kv4.3 – SA.          
n = 10-13 (Table 6.1).  
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time that O-linked sialic acids modulate Kv channel gating through isoform-
specific mechanisms. 
 
Sialic acids modulate Kv4.2 and Kv4.3 activation 
Kv4.2 and Kv4.3 are members of the Shal subfamily of Kv channels and are 
rapidly activating and inactivating (A-type) channels. Neither Kv4.2 or Kv4.3 
contain an external N-glycosylation site75. To determine whether Kv4.2 and Kv4.3 
sialylation modulated channel gating, the two isoforms were expressed 
individually in CHO cells under conditions of full and reduced sialylation, and 
whole cell K+ currents were characterized. Figure 6.1 shows the conductance-
voltage relationships measured for each isoform as expressed in Pro5 (+ SA) 
and Lec2 (-SA) cells. Note that the G-V relationship was shifted significantly to 
more depolarized potentials for both isoforms under conditions of reduced 
sialylation. The voltages of half-activation for Kv4.2 and Kv4.3 under conditions of 
reduced sialylation were shifted to more depolarized potentials by 16 mV and 8 
mV, respectively, (Table 6.1).  
 
Kv4.2 and Kv4.3 fast inactivation and recovery from fast inactivation are not 
altered by changes in channel sialylation 
Kv4.2 and Kv4.3 are rapidly activating and inactivating (A-type) channels that 
undergo N-type fast inactivation. N-type inactivation occurs when the N-terminus 
of the protein occludes the pore from the cytoplasmic face, effectively blocking 
the flow of ions75. For Kv4.2 and Kv4.3, channel sialylation had no measurable  
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Figure 6.2. Kv4.2 and Kv4.3 fast inactivation and recovery from fast 
inactivation are not affected by sialic acids. 
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Figure 6.2. Fast inactivation and recovery from fast inactivation for Kv4.2 and 
Kv4.3 expressed under conditions of full and reduced sialylation. Data are mean 
± SEM, A, B: Steady-state channel availability (inactivation). Curves are single 
Boltzmann distribution fits to the data (lines). Insets represent inactivation (hinf) 
current traces recorded from Pro5 cells, C, D: Recovery from fast inactivation at 
a -140 mV recovery potential. Data are mean ± SEM fractional current. Curves 
are single exponential fits to the data, A, C: Black Circles: Kv4.2 + SA; Gray 
Circles: Kv4.2 – SA, B, D: Black Squares: Kv4.3 + SA; Gray Squares: Kv4.3 - SA. 
n = 8-13 (Table 6.1).  
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Table 6.1. The measured gating parameters for Kv4.2 and Kv4.3 ± sialic acid. 
 
Construct n Va Ka Vi Ki 
  mV mV mV mV 
Kv4.2 + SA  8 -20.7 ± 1.7 15.6 ± 0.9  -66.2 ± 2.8  -7.8 ± 0.6  
Kv4.2 – SA  11 -4.5 ± 2.2* 16.9 ± 0.6  -67.2 ± 2.6  -6.7 ± 0.4  
Kv4.3 + SA  10 -15.4 ± 2.2 12.3 ± 0.5  -51.3 ± 2.1  -5.9 ± 0.9  
Kv4.3 – SA  13 -7.8 ± 1.5* 15.4 ± 0.7* -57.3 ± 2.5  -6.1 ± 0.4  
 
Table 6.1. Data are the mean ± SEM. Va: Voltage of half-activation.                   
Ka: Boltzmann activation slope factor. Vi: Voltage of half-inactivation.                 
Ki: Boltzmann inactivation slope factor. Significance was tested using a two-tailed 
Student’s t-test to compare gating parameters under conditions of reduced 
sialylation (Lec2, - SA) with control conditions (Pro5, + SA). * = significance 
(p<0.005). 
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effect on steady-state fast inactivation or on the recovery from fast inactivation 
(Figure 6.2, Table 6.1).  
 
Kv2.1 is not N-glycosylated  
Kv2.1 is a delayed rectifier channel that produces a slowly inactivating current 
and contains one N-glycosylation site located on the S3-S4 linker75. Previously, it 
was found that Kv2.1 is not N-glycosylated in the brain211. To determine whether  
Kv2.1 is N-glycosylated in Chinese Hamster Ovary cells, a Kv2.1 N-glycosylation 
mutant (Kv2.1N283Q) was generated by mutating the asparagine residue (N) that 
initiates the potential N-glycosylation consensus sequence to a glutamine (Q). In 
addition, fully glycosylated Kv2.1 channel protein was treated with the 
glycosidase PNGase-F to remove the full N-glycan structure, as previously 
performed by our lab218. Immunoblot analyses showed the electrophorectic 
mobilities of Kv2.1, Kv2.1N283Q, and Kv2.1 treated with PNGase-F were nearly 
identical, indicating that Kv2.1 expressed in CHO cells is not N-glycosylation 
(Figure 6.3).   
 
Sialic acids modulate Kv2.1 activation  
To determine whether sialic acids impact Kv2.1 channel function, channel gating 
was studied under conditions of full and reduced sialylation by expressing Kv2.1 
in Pro5 (+ SA) and Lec2 (- SA) cell lines. Under conditions of reduced sialylation, 
Kv2.1 activated at more depolarized potentials than the fully sialylated channel  
 
119 
 
Figure 6.3. Kv2.1 is not N-glycosylated. 
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Figure 6.3. Immunoblot of Kv2.1N283Q and untreated and PNGase-F treated 
Kv2.1.Samples were fractionated on a 6.5% SDS gel and probed with an anti-
Kv2.1 monoclonal antibody (1:1000 dilution, see Materials and Methods).        
Lane 1: Kv2.1N283Q, Lane 2: Kv2.1 + PNGase-F, Lane 3: Kv2.1. Molecular weight 
marker is denoted to the left of lane 1. 5 μg of protein loaded per lane. 
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Figure 6.4. Sialic acids modulate Kv2.1 activation. 
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Figure 6.4. A. G-V relationships for Kv2.1 under conditions of full and reduced 
sialylation. Data are the mean normalized peak conductance ± SEM and are fit to 
a single Boltzmann relationship (lines). Black Triangles: Kv2.1 WT + SA (Pro5); 
Gray Triangles: Kv2.1 WT – SA (Lec2). Inset: Typical whole cell Kv2.1 current 
traces. n = 12-14 (Table 6.2), B. Activation time constants (τn) for Kv2.1 in the 
presence and absence of sialylation. Data are mean ± SEM. Lines are non-
theoretical point to point. Symbols are the same as in A. Dotted line represents 
the data from Kv2.1 expressed in Lec2 cells shifted by the ΔVa. Inset: Current 
traces during a -20 mV test potential. The scaling factor used to normalize the 
currents was 1.85. Black traces: Kv2.1 + SA; Gray traces: Kv2.1 – SA. n = 12-14. 
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Table 6.2. Gating parameters measured for Kv2.1. 
 
Construct n Va Ka 
  mV mV 
Kv2.1 + SA  14 -12.9 ± 1.9 13.6 ± 03  
Kv2.1 – SA  12 -3.7 ± 1.8* 13.3 ± 0.4  
 
 
Table 6.2. Data are mean ± SEM. Va: Voltage of half-activation. Ka: Boltzmann 
activation slope factor. Significance was determined using a two-tailed Student’s 
t-test to compare gating parameters under conditions of reduced sialylation 
(Lec2, - SA) with control conditions (Pro5, + SA).* = significance (p<0.005). 
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(Figure 6.4). The G-V relationship for the less sialylated Kv2.1 was shifted by a 
significant depolarizing ~9 mV from the G-V relationship measured for fully 
sialylated channels. Likewise, the Va was shifted to more depolarized potentials 
for the less sialylated channel, indicating a stronger depolarization is required to 
activate Kv2.1 in the absence of sialic acids (Figure 6.4, Table 6.2).   
 
Sialic acids impose an apparent electrostatic effect on Kv2.1, Kv4.2, and 
Kv4.3 channel gating  
Sialic acids are negatively charged residues at physiological pH that may 
contribute to the external negative surface potential, impacting voltage-
dependent channel gating. With increased negative surface charge, the channel 
would activate at less depolarized potentials. That is, if sialic acids contribute to a 
negative surface potential, then channels with greater levels of sialic acids would 
be predicted to activate at less depolarized potentials than channels with reduced 
levels of sialylation. The presence of external divalent cations will screen this 
surface potential and reduce the impact of the negatively charged sialic acid 
residues on channel gating212,213. Here, the Va for Kv4.2, Kv4.3, and Kv2.1 as 
expressed under conditions of full and reduced sialylation were measured and 
compared at two different divalent cation concentrations. The data show the Va 
for each isoform as expressed under conditions of full sialylation was more 
sensitive to changes in external divalent concentrations, while the Va for the 
isoforms expressed in Lec2 cells were minimally affected by changes in external 
divalent concentrations (Figure 6.5). These data are consistent with sialylation  
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Figure 6.5. Sialic acids modulate Kv2.1, Kv4.2, and Kv4.3 activation through 
electrostatic mechanisms. 
 
Δ V
a w
ith
 1
0-
fo
ld
 In
cr
ea
se
 in
 [C
at
io
n O
2+
] (
m
V
)
-5
0
5
10
15
20
Kv4.2 + SA 
Kv4.2 - SA 
Kv4.3 + SA
Kv4.3 - SA 
Kv2.1 + SA 
Kv2.1 - SA 
Kv4.2 Kv4.3 Kv2.1
14 mV
6 mV
7 mV
*
*
*
 
 
Figure 6.5. The Va for Kv2.1, Kv4.2, and Kv4.3 expressed under conditions of full 
and reduced sialylation were measured and compared at normal and low (10-fold 
reduction) external divalent cation concentrations. Data are mean ± SEM 
hyperpolarizing shifts in Va measured. Note the significantly larger shift in Va in 
the presence of sialylation. Solid bars: + SA; Patterned Bars: – SA. n = 3-4. 
Significance (*) tested using two-tailed Student’s t-test comparing Va shifts with a 
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tenfold increase in external divalent cation concentration as measured in Pro5 
versus Lec2 cells (p<0.005). 
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altering the activation of Kv4.2, Kv4.3, and Kv2.1, through electrostatic 
mechanisms. 
 
Kv2.1, Kv4.2, and Kv4.3 channels are O-glycosylated and sialylated 
Data shown here indicate that sialic acids attached to three Kv isoforms 
differentially impact channel activation. Previous efforts to determine how glycans  
modulate channel function typically questioned how N-linked glycans impact 
channel function. There have been no previous studies of putative effects of O-
glycans on voltage-gated ion channel function. However, Kv4.2 and Kv4.3 do not 
contain N-glycosylation sites, and we show here that Kv2.1 is not N-glycosylated 
as expressed in CHO cells. Thus, the data suggest that sialic acids attached 
through O-linkages are responsible for the observed effects on channel gating.   
O-glycosylation does not have a recognized consensus sequence; however, it is 
known to be attached to serines or threonines with prolines, alanines, serines, 
and threonines among the neighboring residues176-182. Thus, numerous potential 
O-glycosylation sites are located on each Kv channel (i.e., many externally 
located serine and threonine residues), making removal of all potential O-
glycosylation sites through mutagenesis nearly impossible. To overcome this 
limitation, Click chemistry was employed to identify whether Kv2.1, Kv4.2, and 
Kv4.3 were O-glycosylated and sialylated185,235,237,267. Tetraacetylated azido-
modified sugars, Ac4GalNAz (O-glycosylation) or Ac4ManNAz (sialylation), were 
incorporated into protein glycan structures and bound with biotin-alkyne (Figure 
6.6). Because of the strong interaction between streptavidin and biotin, the  
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Figure 6.6. Metabolic incorporation of labeled sugars utilizing Cu(I)- 
catalyzed cycloaddition.  
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Figure 6.6. A. Azide-modified sugars are metabolically incorporated into cell 
surface protein glycan structures through the permissive nature of the 
oligosaccharide biosynthesis pathway, B. An azide-modified N-
acetylmannosamine (ManNAz) is incorporated into the sialic acid biosynthetic 
pathway generating an azide-modified sialic acid residue. An azido analog of N-
acetylgalactosamine (GalNAz) can be metabolically introduced at the core 
position of mucin-type O-linked glycoproteins, C. The Cu(I)-catalyzed 
cycloaddition reaction occurs between an azide (attached to the protein) and a 
biotin-alkyne to form a stable triazole conjugate, which can be detected via a 
steptavidin column. Figures adapted from Prescher and Bertozzi, 2005268 and 
www.Invitrogen.com, 2008. 
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biotinylated samples were incubated with streptavidin-bound magnetic beads to 
isolate only those proteins with the modified sugar incorporated into the protein 
glycan structures (see Materials and Methods). Immunoblot analysis of the 
Ac4GalNAz and Ac4ManNAz samples detected bands at the appropriate 
molecular weights for Kv2.1, Kv4.2, and Kv4.3 under both conditions (Figure 6.7). 
These data indicate that each Kv isoform tested is O-glycosylated and sialylated,  
supporting the hypothesis that O-linked sialic acids are responsible for the effect 
of sialic acids on Kv2.1, Kv4.2, and Kv4.3 gating.  
 
Discussion 
O-linked sialylation modulates the gating of Kv2.1, Kv4.2, and Kv4.3 through 
apparent electrostatic mechanisms 
Here, we examined the role of O-linked sialic acids on gating of Kv2.1, Kv4.2, and 
Kv4.3. Figures 6.1 and 6.4 show that a reduction in sialic acids causes a 
significant depolarizing shift in the G-V relationship for all three isoforms studied. 
Kv4.2 and Kv4.3 do not contain an N-glycosylation consensus site within their 
extracellular amino acid sequence and therefore, cannot be N-glycosylated. 
Kv2.1 contains one N-glycosylation site on its S3-S4 linker, but as predicted, the 
data shown in figure 6.3 indicate that this site is not N-glycosylated on channels 
expressed in CHO cells, consistent with previous studies in COS-1 cells and rat 
brain211. Several possible explanations for the lack of glycosylation of the 
potential Kv2.1 site exist. A likely explanation is that the N-glycosylation site, 
located on the S3-S4 linker, is not accessible to the glycosylation machinery,  
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Figure 6.7. Kv2.1, Kv4.2, and Kv4.3 channels are O-glycosylated and 
sialylated. 
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Figure 6.7. Click chemistry confirmed the presence of O-glycosylation and 
sialylation attached to Kv2.1, Kv4.2, and Kv4.3. Immunoblots of Kv2.1, Kv4.2, and 
Kv4.3 lysates. Samples were fractionated on a 6.5% SDS gel and probed with 
anti-Kv2.1, anti-Kv4.2, or anti-Kv4.3 monoclonal antibodies (1:100-1000 dilution, 
see Materials and Methods).Lanes 1: Control samples, Lanes 2: Ac4ManNAz -
labeled (sialic acid) samples, and Lanes 3: Ac4GalNAz-labeled (O-glycosylated) 
samples. Molecular weight marker is denoted to the left of lane 1. A. Kv2.1,       
B. Kv4.2, C. Kv4.3.  
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thereby preventing addition of glycosylation (as suggested by the Kv channel 
crystal structures)84,85.  
 
Although Kv2.1, Kv4.2, and Kv4.3 are not N-glycosylated, we observed isoform-
specific effects of sialylation on channel gating. A reduction in sialylation caused 
rightward, depolarizing shifts in the G-V relationships that were unique in 
magnitude for each isoform (Figures 6.1 and 6.4, Tables 6.1 and 6.2). Sialic 
acids modulate activity of each isoform through apparent electrostatic 
mechanisms.   
 
The data indicate that negatively charged sialic acids modulate activation of 
Kv2.1, Kv4.2, and Kv4.3 through electrostatic mechanisms. Based on the surface 
potential theory, negative charges on the outer surface of the membrane 
generate a surface potential. Specifically, with a reduction in external negative 
charges, a hyperpolarization would be sensed by the channel gating mechanism, 
and thus, channel activation would require a greater depolarization212,213. 
Extracellular divalent cations should act to screen the effects of negatively 
charged sialic acid residues on surface potential, effectively reducing the 
negative surface potential. We found that channels expressed in the fully 
sialylating Pro5 cells were more sensitive to changes in extracellular divalent 
cation concentration than channels expressed in the reduced sialylating Lec2 
cells (Figure 6.6). The data indicate that sialic acids modulate Kv2.1, Kv4.2, and 
Kv4.3 activation through electrostatic mechanisms 212,213. Further, changes in 
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sialylation shifted the G-V curve for each isoform nearly linearly, with little or no 
effect on the slope. This suggests that changes in Kv2.1, Kv4.2, and Kv4.3 
sialylation primarily alter the negative surface potential, with little to no effect on 
the stability of channels among functional states. This is distinct from that 
previously described for Kv1 isoforms, in which N-glycans conferred stabilizing 
effects on Kv1 channel states214,215.  
 
Steady-state inactivation and recovery from inactivation of Kv4.2 and Kv4.3 were 
not significantly impacted by changes in channel sialylation (Figure 6.2, Table 
6.1). Most previous studies showed that the surface charge effects of sialic acids 
on channel voltage-dependent gating similarly affect all voltage-dependent gating 
mechanisms, suggesting that the surface potential produced by sialic acids 
contributes uniformly to the electric field sensed by each channel gating 
mechanism216,217. Typically, with a linear change in channel activation along the 
voltage axis, as observed in Figure 6.1A, there is a consistent shift in channel 
steady-state inactivation voltage dependence. In this study, we show that sialic 
acids shift only the G-V relationship for Kv4.2 and Kv4.3, with no effect on 
inactivation or recovery from inactivation. The data also indicate that sialic acids 
modulate activation voltage by contributing to the negative surface potential.  
Together, these data suggest that sialic acids affect channel gating through 
electrostatic mechanisms, but do not confer a uniform effect on all voltage-
dependent gating mechanisms. One likely explanation is that sialic acids impose 
a unique, inhomogeneous effect on the electric field sensed by the channel 
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gating mechanisms (for Kv4.2 and Kv4.3 isoforms), such that only activation is 
affected. Such a phenomenon has not been previously described for Kv channel 
gating. 
 
A single previous report indicated that sialic acids impact gating of Kv4.3217.  
However, the study did not determine the sialic acid linkages responsible for the 
effect on channel gating. Our data are in general agreement with the previous 
report; Kv4.3 channel activation voltage was shifted to depolarized potentials 
under conditions of reduced sialylation. The preceding report indicated a small, 
but significant, shift in channel inactivation voltage that we did not observe. There 
are several possible reasons for the relatively minor differences between our 
data and that previously described, including the use of different external and 
internal solutions to record Kv channel currents. It was shown in the previous 
study that sialolipids contribute at most 3-4 mV to Kv4.3 channel gating. We 
measure a much larger sialic acid-dependent shift for Kv4.3 gating (~ 8 mV) and 
an even greater shift for Kv4.2 gating (~16 mV), indicating that most of the effect 
of sialic acids on Kv4 gating is caused by O-linked channel sialic acids. 
 
In addition, while Kv4.2 and Kv4.3 are homologous proteins, changes in channel 
sialylation have a much greater impact on Kv4.2 (the Va was shifted by 16 versus 
8 mV). This suggests that O-linked sialic acids attached to Kv4.2 and Kv4.3 
impact channel activation differently. That is, Kv4.2 and Kv4.3 O-linked sialic 
acids apparently are different in number or location relative to the channel 
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activation mechanisms. Significant further studies are required to determine 
whether changes in the number and/or location of O-linked sialic acid impact Kv4 
channel activation.  
 
Summary 
We showed that Kv2.1, Kv4.2, and Kv4.3 are O-glycosylated and sialylated in 
CHO cells using Click chemistry (Figure 6.6) and that O-linked sialic acids 
modulate gating of each isoform uniquely (Figures 6.1 and 6.4). No previous 
works link Kv channel O-glycosylation to channel gating. Therefore, the data 
presented in this study reflect a novel finding that Kv channel gating is modulated 
by O-linked sialic acids. Implications of this study are broad, given the abundant 
and ubiquitous nature of glycosylation. 
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CHAPTER 7 
FINAL DISCUSSION 
During arrhythmic episodes, cardiac conduction and rhythm are altered. ECGs 
and APs measure excitability in the heart and cardiomyocytes; from these, we 
can pinpoint which currents are modulated under developmental and pathological 
conditions. As previously discussed in detail, Kv currents are responsible for AP 
repolarization, returning the membrane potential to hyperpolarized potentials. 
Post-translational modification of Kv channels may be one mechanism by which 
channel function, and thus AP repolarization, can be altered. Therefore, the aim 
of this study was to determine whether aberrant glycosylation, via reductions in 
sialylation, have a direct effect on cardiac excitability by impacting cardiac Kv 
currents and AP repolarization; a knockout mouse model, treatment with 
glycosidases, and a heterologous expression system were utilized to perform 
these studies.  
 
ST3Gal-IV deficient mice show alterations in ECGs 
The knockout mouse strain used in this study, ST3Gal-IV(-/-) mice, does not 
demonstrate an obvious, distinct phenotype. However, a previous study 
determined that mice lacking ST3Gal-IV have a deficiency in Von Willebrand 
factor (VWF), a plasma sialoglycoprotein with 24 putative glycosylation sites that 
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stabilizes coagulation factor VIII. Because of this, ST3Gal-IV(-/-) mice showed an 
increased bleeding time, a substantial decrease in platelets (30% of normal), and 
can develop thrombocytopenia due to elevated platelet clearance. The observed 
effects are likely the result of a decreased VWF half-life caused by a reduction in 
sialylation that exposes galactose linkages, which have been implicated as 
asialoglycoprotein receptor ligands219. These results suggest that a deficiency in 
ST3Gal-IV can have a multitude of effects on normal physiologic processes. 
 
Mice with a knockout of the sialyltransferase ST3Gal-IV were utilized for 
telemetric analysis of ECGs. ST3Gal-IV(-/-) mice demonstrated slower heart rates 
and showed putative changes in atrial conduction. This was observed as 
broadened P waves and R-R segments on the ECG (Figure 3.1). An increased 
incidence of arrhythmic beats and greater variation between beats was noted in 
the ST3Gal-IV(-/-) animals, suggesting that the loss of a single sialyltransferase 
can promote arrhythmogenic conditions; conduction abnormalities were not 
detected in the littermate controls. However, the ECG data does not give a clear 
picture of exactly how cardiac excitability is impacted by ST3Gal-IV. 
Nonetheless, a reduction in sialic acids attached to ion channels may be one 
mechanism, as channel proteins typically are glycosylated/sialylated heavily. For 
example, the cardiac sodium channel, Nav1.5, possesses 13 putative, 
extracellular N-glycosylation sites; changes in sialylation have been shown to 
alter Nav1.5 function218. In addition, pacemaker activity may be impacted by 
aberrant sialylation of HCN channels, which have one putative N-glycosylation 
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site on the S5-S6 linker269. The potential alteration in HCN activity likely will 
modulate pacemaker current (If) in the SA node, thus affecting normal cardiac 
rhythm. Changes in glycosylation, namely sialylation, may alter the contribution 
of the autonomic nervous system as well. Parasympathetic input contributes to 
beat-to-beat pacing of cardiac rhythm14; therefore, reduced glycosylation might 
increase vagal activity, which would decrease heart rate and (potentially) the 
susceptibility to arrhythmias. On the other hand, impaired N-glycosylation is one 
mechanism by which neural norepinephrine transporter (NET) density is reduced 
at sympathetic nerve endings270. This will lead to diminished norepinephrine (NE) 
uptake, which is a salient feature of cardiac failure271,272. Thus, the observed 
susceptibility to arrhythmic beats in ST3Gal-IV(-/-) mice, as deduced from ECG 
analysis, may be the result of multiple sialic acid-dependent effects.  
 
Regulated and aberrant glycosylation modulates atrial, but not ventricular, 
action potentials  
In order to evaluate the effects of ST3Gal-IVdeficiency more thoroughly, action 
potentials were recorded from isolated neonatal atrial and ventricular myocytes. 
In this way, any potential influence of the autonomic nervous system and 
pacemaker cells should be eliminated. All experiments were performed in the 
neonate, as data suggested that sodium channels are less sialylated in neonatal 
ventricles compared to neonatal atria218.  
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Action potentials measured from ST3Gal-IV(-/-) atrial myocytes were prolonged 
significantly compared to control (Figure 3.2). Treatment of control atrial 
myocytes with neuraminidase or PNGase-F to cleave sialic acids or N-
glycosylation, respectively, lengthened action potential duration similar to that of 
the knockout (Figures 4.1 and 4.2). Specifically, the action potential durations at 
10%, 50%, and 90% repolarization were lengthened by ~25-150% in ST3Gal-  
IV(-/-), neuraminidase treated, and PNGase-F treated atrial myocytes (Tables 3.1 
and 4.1).  
 
A reduction in sialylation slowed the AP rising phase in atrial myocytes. The time 
to peak was prolonged in ST3Gal-IV(-/-) and neuraminidase treated atrial 
myocytes, which suggests an effect on Nav channel function. However, time to 
peak was unaffected with PNGase-F treatment (Table 4.1). This difference could 
be achieved by contribution of O-linked sialic acids, which are not removed upon 
PNGase-F treatment, to AP production. Incomplete removal of N-glycans with 
PNGase-F treatment may also account for the similar time to peak as control. 
Chapter six shows O-linked sialylation alters gating of Kv channel isoforms 
expressed in an in vitro system; therefore, the slight variation in AP parameters 
between ST3Gal-IV(-/-), neuraminidase, and PNGase-F treated myocytes could 
be a modulatory effect of O-linked sialic acids (Tables 3.1 and 4.1).A previous 
study from our lab reported similar effects of altered sialylation on AP 
parameters; the rate of depolarization and action potential duration were 
lengthened significantly in STX(-/-) atrial myocytes189. The extended atrial AP 
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repolarization phase observed in ST3Gal-IV(-/-), STX(-/-), and glycosidase treated 
myocytes suggests Kv channel activity is modulated as well. A rightward shift in 
the voltage-dependence of activation would delay initiation of AP repolarization, 
thus lengthening the repolarization phase. 
 
Interestingly, ventricular AP parameters were not affected in ST3Gal-IV(-/-) or 
STX(-/-) mice; AP parameters also were not altered significantly in glycosidase 
treated ventricular myocytes (Figures 3.3 and 4.3). Human ventricular APDs, due 
to a lengthened plateau phase, are longer than atrial APDs. In the neonatal 
mouse, the same holds true. If voltage-gated ion channels expressed in the 
neonatal ventricle are less sialylated than the atria, as shown for sodium 
channels218, the chamber-specific differences in APD may be accounted for (at 
least partially in the neonate) by changes in sialylation. Together, these data 
suggest the presence of normal glycosylation structures is not required for 
production of typical neonatal ventricular action potentials. However, a previously 
published study determined that adult ventricular myocytes treated with 
neuraminidase to remove sialylation displayed lengthened APDs and an 
increased incidence of early after depolarizations217. One possible explanation 
for the conflicting data is adult ventricle has a greater portion of complex, 
biantennary glycans than neonatal ventricle189,218. Furthermore, N-glycosylation 
structures from adult atrial and ventricular tissue have a significantly larger 
proportion of sialic acids than do neonatal cardiac samples189. Hence, adult 
ventricular action potentials may be more sensitive to changes in glycosylation 
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than their neonatal counterparts. Reduced sialylation of neonatal ventricular 
myocytes should slow conduction of APs through the ventricles of the neonatal 
animal compared to the adult. 
 
With reduced glycosylation, changes in activation of repolarizing Kv 
currents are consistent with the effects reported for APs 
Since alterations in glycosylation demonstrated a significant effect on atrial AP 
repolarization rate, Kv currents that underlie the repolarization phase were 
recorded from ST3Gal-IV(-/-), glycosidase treated (neuraminidase or PNGase-F), 
and control atrial and ventricular myocytes. Steady-state activation of Ito and 
IK,slow, two components of IK, was shifted to more depolarized potentials in 
knockout and glycosidase treated atrial myocytes, observed in Figures 3.4 and 
4.4 as depolarizing shifts in the G-V relationships and the Va. Furthermore, 
treatment of atrial myocytes with PNGase-F did not result in a further affect on Ito 
or IK,slow activation compared to ST3Gal-IV(-/-) and neuraminidase treated atrial 
myocytes, suggesting that N-glycosylation does not contribute an additional 
effect and sialic acids exert the entire effect of sugars on Ito and IK,slow (Figure 
4.4). These data support the atrial AP findings and our Kv1.5 data in the 
heterologous expression system, as this isoform demonstrated no significant 
effect of N-glycosylation (other than sialic acids) on channel gating (Chapter 5). 
Treatment with neuraminidase produced a slightly greater depolarizing shift in 
the Va of atrial IK,slow compared to PNGase-F treatment. Data from chapters five 
and six suggest that O-linked sialic acids alter Kv2.1 gating, while N-linked 
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sialylation is responsible for the entire effect of sialic acids on Kv1.5 channel 
function. Thus, O-linked sialic acids attached to Kv2.1 may be responsible for the 
additional effect on atrial IK,slow activation observed with neuraminidase treatment. 
Since Kv4.2 and Kv4.3 are not N-glycosylated (Chapter 6), the effects of N-
glycosylation on Ito activation are likely due to N-linked SAs attached to Kv1.4. 
Although no effect of a reduction in glycosylation was observed on Kv1.4 gating 
in CHO cells (Chapter 5), it is possible that in vivo channels may be impacted 
differently by changes in glycosylation, as previously found for cardiac Nav1.5 
channels218,220. This may be because the channels are more sialylated in vivo 
than in CHO cells. Chapter six shows that O-linked sialic acids exert an effect on 
Kv4.2 and Kv4.3 activation. Hence, the slightly larger shift in the Va for atrial Ito 
following neuraminidase treatment (compared to PNGase-F treatment) may be 
due to O-linked sialic acids altering Kv4.2 and/or Kv4.3 gating. Consistently, a 
study from our lab showed that steady-state and kinetic activation of murine atrial 
Nav currents was shifted to more depolarized potentials (by ~7 mV) in STX(-/-) 
neonatal myocytes189. Our lab also published that activation of Nav currents 
recorded from rat neonatal atrial myocytes was shifted to more depolarized 
potentials upon treatment with neuraminidase218. The alteration in Nav currents 
measured from STX(-/-) and rat neonatal atrial myocytes correlates with the 
slowed time to peak observed in STX(-/-) and ST3Gal-IV(-/-) atrial APs. 
 
Neonatal ventricular Ito and IK,slow were not impacted by changes in glycosylation. 
That is, ST3Gal-IV(-/-) and glycosidase treated ventricular myocytes produced Kv 
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currents similar to those recorded from control (Figures 3.5 and 4.5). Since we 
observed no significant alteration in ventricular repolarization, these results were 
predicted. A study by our lab consistently showed no affect on neonatal 
ventricular Nav currents collected from STX(-/-) mice189. On the other hand, 
published data from our lab also suggests that treatment with neuraminidase 
caused depolarizing shifts in steady-state activation and inactivation of Nav 
currents recorded from adult rat ventricular myocytes. Similarly, Ufret-Vincenty, 
et al found that sialic acids modulate murine Ito, but not IK,slow, in adult ventricular 
myocytes. These contradictory results are not surprising given that neonatal 
ventricle has less complex glycan structures (and likely fewer sialic acid 
residues) than adult ventricle189,218. The differences in half-activation voltage of Ito 
and IK,slow between the atria and ventricle not accounted for by changes in 
glycosylation are likely due to differential expression of Kv channel isoforms. For 
example, Kv1.5, which demonstrated the largest shift in Va upon a reduction in 
sialylation as expressed in CHO cells, is expressed at greater levels in the atria 
than the ventricle273. In all, glycosylation affects the production of neonatal 
cardiac potassium currents and, thus, action potentials through chamber-specific 
mechanisms. 
 
Kv channel activation is modulated by reduced glycosylation in isoform-
specific manners 
To fully appreciate the glycosylation-specific effects on cardiac K+ currents and 
excitability, the specific channel isoforms underlying the production of Ito and 
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IK,slow must be examined under conditions of full and reduced glycosylation. 
Briefly, Kv1.4, Kv4.2, and Kv4.3 produce Ito, which perpetuates initial AP 
repolarization; IK,slow is generated by Kv1.5 and Kv2.1. For functional studies, 
however, these channel isoforms were classified by sub-family and by the type of 
glycosylation attached to each channel. The Kv1 isoforms each contain one 
putative N-glycosylation site on the S1-S2 linker and, as discussed in Chapter 5, 
Kv1.4 and Kv1.5 are N-glycosylated and sialylated. Kv4.2 and Kv4.3 do not have 
an extracellular N-glycosylation site and, therefore, are not N-glycosylated. One 
putative N-glycosylation site is located on the S3-S4 linker of Kv2.1; however, 
recent studies suggest this site is inaccessible to the cell’s glycosylation 
machinery84,85 and that Kv2.1 expressed in CHO cells (Chapter 6) and the 
mammalian brain is not N-glycosylated211. Thus, the Kv isoforms investigated in 
this study are categorized by the presence or absence of N-glycosylation.  
 
Gating of two Kv1 isoforms is modulated uniquely by glycosylation  
Gating parameters of two homologous Shaker K+ channels, Kv1.4 and Kv1.5, 
were studied under conditions of full and reduced glycosylation. N-linked sialic 
acids contribute to the voltage-dependence of channel gating for Kv1.5 through 
electrostatic mechanisms (Figures 5.2 and 5.4), but have no affect on Kv1.4 
gating (Figure 5.5). These data are novel in several respects, including: 1) Kv1.4 
is the only member of the Kv1 subfamily in which the attached N-glycans have no 
measurable effect on channel gating, 2) With reduced sialylation/glycosylation,  
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Kv1.5 exhibited the largest depolarizing shift in voltage-dependence of activation 
of any member of the Kv1 subfamily, and 3) Kv1.5 is the only member (to date) of 
the Shaker Kv channel family for which N-linked sialic acids account fully for the 
impact of N-glycans on channel function, produced solely by an electrostatic 
effect. Because Kv1.5 produces an important repolarizing current in the human 
atria, IKur, altered Kv1.5 channel function, whether through regulated expression 
or glycosylation, could lead to significant changes in AP repolarization122. 
 
O-linked sialic acids alter activation of Kv2.1, Kv4.2, and Kv4.3 
In chapter six, we showed that reduced sialylation, likely O-linked, caused unique 
depolarizing shifts in steady-state activation voltage for three Kv channel isoforms 
that are not N-glycosylated (Figures 6.1 and 6.4). An electrostatic mechanism is 
apparently responsible for these effects, with O-linked sialic acids contributing to 
the external negative surface potential (Figure 6.5). Inactivation and recovery 
from inactivation were not impacted significantly by reduced sialylation of the two 
rapidly inactivating isoforms, Kv4.2 and Kv4.3. This suggests a non-homogenous 
influence of Kv4 sialic acids on the electric field sensed by the activation, 
inactivation, and recovery gating mechanisms (Figures 6.1 and 6.2). Together, 
the data indicate that O-linked sialic acids modulate gating of Kv channels that 
are not N-glycosylated, and that this modulation is unique for each isoform. This 
is the first study to report direct effects of O-glycans on ion channel gating. 
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Physiological and pathological relevance 
Over 1% of the human genome is implicated in glycosylation of proteins and 
lipids, which occurs through a highly regulated process. Due to the abundance 
and complexity of glycosylation, proper regulation is vital to normal protein 
function. Protection, stabilization, and organization are among the responsibilities 
of glycosylation. For instance, glycan structures act as antigens, determining 
blood type. 
 
Aberrant glycosylation also can result in pathological consequences or 
exacerbate another condition. As discussed in the introduction, Congenital 
Disorders of Glycosylation are multi-symptom disorders in which the assembly or 
processing of glycans is altered by mutation. In CDG type-Ia (CDG-Ia), the 
central nervous system (CNS) is traditionally the main site affected, as noticeable 
mental and neuromuscular retardation persists; however, patients also tend to 
exhibit cardiac failure274. The results presented here suggest that alterations in 
glycosylation can impact cardiac excitability by modulating the Kv currents 
involved in AP repolarization. Thus, abnormal or reduced glycosylation in CDG-Ia 
patients may alter ion channel activity, in particular that of Kv channels, changing 
the AP waveform and leading to cardiac arrhythmias and failure. Additionally, 
glycosylation has been shown to enhance ion channel function; therefore, a 
decrease in the number of glycans could diminish the activity of ion channels as 
well as other proteins. For example, nerve conduction velocity is slowed in   
CDG-Ia patients274. This could be due to changes in the activity of Nav channels, 
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decreasing the excitability of the cell. Furthermore, altered function of 
glycoproteins involved in myelination could display a similar outcome by 
lessening the amount of myelin attached to an individual neuron. Together with 
the effect of reduced glycosylation on cardiac ion channels, the alteration in 
conduction velocity could manifest the presented cardiac failure. Some of the 
cardiac maladies detected in patients with the sialic acid-cleaving parasitic 
disorder, Chagas disease, may be generated in a similar manner. 
 
As detailed in the introduction, Chagas disease is a parasitic disorder caused by 
T. cruzi, which afflicts approximately 18 million people worldwide. Initial stages of 
host cell invasion and host-parasite interactions are mediated by trans-sialidase, 
an enzyme that cleaves and transfers SA residues from host cells, and SA 
acceptors on the parasitic cell surface208,275. Significant quantities of trans-
sialidase are released into the cytosol of host cells and, eventually, into the 
extracellular space275. Thus, sialic acids from glycoproteins, such as Kv channels, 
and glycolipids may be removed as a result. This likely would decrease the 
activity of cardiac ion channels and alter AP production (as described in chapters 
three and four), leading to cardiac conduction and rhythm disruptions. In fact, 
atrioventricular and intraventricular blockages are common in mice infected with 
T. cruzi276. Chronically, patients infected with T. cruzi typically develop 
myocarditis and/or dilated congestive cardiomyopathy, with one hallmark of the 
disease being ventricular apical aneurysms. Because of the destruction of 
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conduction tissues and potentially desialylation of ion channels, cardiac 
arrhythmias typically arise277.  
 
Dystroglycan, a membrane protein that binds to components of the extracellular 
matrix (ECM), contains an estimated 50 O-glycosylation sites (many of which 
likely are sialylated) in the middle third of the molecule, constituting 
approximately 50% of the molecular weight278. When O-glycosylation is removed 
from α-dystroglycan, laminin binding is inhibited, dissociating the ECM from the 
muscle membrane279. Glycosylation-dependent congenital muscular dystrophies 
(CMDs) are defined by altered α-dystroglycan glycosylation leading to wasting of 
skeletal muscles. However, cardiac muscle can be severely affected as well. 
Atrial fibrillation or flutter was observed in patients with myotonic muscular 
dystrophy type 1 (MD1), Emery-Dreifuss muscular dystrophy (EDMD), 
Duschenne muscular dystrophy (DMD), and Becker muscular dystrophy (BMD) 
in particular. Consistently, our data suggest that 
hypoglycosylation/hyposialylation results in altered atrial conduction, 
demonstrated by a broadened P wave on the ECG, prolonged atrial APD, and 
changes in the voltage-dependence of two repolarizing atrial Kv currents. Thus, 
the secondary effect of altered cardiac excitability in muscular dystrophy patients 
may be due to changes in O-linked sialic acids attached to cardiac potassium 
channels. Variations in Kv channel function via reduced glycosylation/sialylation 
also may contribute to slowing of neural conduction, as a host of brain defects 
are associated with certain types of muscular dystrophy278.  
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Alterations in glycosylation have been linked to generation or exacerbation of 
various other diseases. For example, IgA nephropathy (IgAN) is characterized by 
aggregation of hypoglycosylated and hyposialylated IgA1, which forms immune 
complexes that promote glomerular inflammation200,202. Mutations in the 
glycosyltransferase PPGalNAc-T3 are responsible for some forms of familial 
tumoral calcinosis due to production of under-glycosylated FGF23 (a phosphate 
regulating hormone)197. This leads to prematurely cleaved FGF23 and improper 
control of phosphate levels280. Additionally, changes in glycosylation have been 
associated with oncogenic activation and cancer progression281. In fact, knockout 
of the Mgat5 gene, encoding the glycosyltransferase GlcNAc-T5, results in a 
reduced metastatic response282. Based on the data presented in this study, 
individuals with these disorders may be more likely to develop cardiac conduction 
abnormalities, as reduced glycosylation of other proteins, such as Kv channels, 
could result. Since glycosylation is a ubiquitous and abundant modification of 
lipids and proteins, alterations in specific aspects of glycosylation, as in the 
aforementioned diseases, could have secondary effects, such as cardiac 
arrhythmias, that have not yet been linked to a particular disorder. Treatment with 
glycosidases or glycosyltransferases could act to slow the progression of cancer 
in a less toxic manner than current therapies or reverse or lessen the symptoms 
associated with familial tumoral calcinosis. Furthermore, this may prevent the 
potential development of secondary symptoms, such as cardiac failure or 
arrhythmias. 
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Chronic consumption of large quantities of alcohol is associated with atrial 
fibrillation, congestive heart failure, and other cardiomyopathies283,284. Changes 
in SA expression have been observed in patients consuming large amounts of 
ethanol (alcoholics). In fact, SA concentrations were higher significantly in 
alcoholics than in healthy controls. However, there was no distinction between 
those alcoholics with or without liver disease285. Ethanol has been shown to alter 
protein glycosylation and decrease the activity of sialyltransferases286,287; 
therefore, alcoholics may have reduced addition of SA to cardiac channel 
proteins, which, again, may alter ionic currents involved in AP production and 
increase the susceptibility to arrhythmias. Additionally, low density lipoproteins 
(LDL) are glycolipids containing terminal sialic acid residues. Although the 
significance of SAs on lipoproteins has not been clearly identified, SAs have 
been associated with lipoprotein solubility, receptor binding and uptake, and 
cholesterol efflux, among others288. In fact, sialic acids may play a role in early 
atherogenesis, as a previous study showed that desialylation of LDLs induced 
cholesteryl ester accumulation in human aortic smooth muscle289.  
 
As previously mentioned, voltage-gated ion channels contribute to action 
potential initiation and propagation in skeletal muscle, neuronal, and cardiac 
cells. Often, the activities of several Kv channel isoforms are responsible for AP 
repolarization; the AP waveform is modulated (remodeled) through changes in 
the expression, density, and/or distribution of specific Kv isoforms. Changes in 
posttranslational modifications, such as glycosylation, can potentially impact 
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gating of Kv channels, leading to changes in AP waveform217,290,291. Thus, Kv 
channel activity would be modulated by changes in glycosylation and/or 
sialylation that result from remodeling of Kv isoforms (subunit-specific differential 
glycosylation). For example, as Kv1.4, Kv1.5, Kv2.1, Kv4.2, and Kv4.3 expression 
and distribution are regulated, AP repolarization would be altered by the changes 
in Kv channel activity. Because sialylation modulates Kv channel function 
uniquely for each isoform, regulated expression of these Kv isoforms would lead 
to changes in the contribution of sialic acid to AP repolarization. In this incidence, 
no significant modification of Kv channel mRNA expression was noted in ST3Gal-
IV(-/-) atria and ventricles compared to control. These findings confirm that 
modified expression of Kv channels in knockout cardiac tissue does not occur 
and thus, cannot account for the observed changes in APD or Kv currents.  
 
In addition to the relevant isoform-specific effects of glycosylation on channel 
function, AP repolarization may be modulated through a cell-specific process of 
regulated glycosylation, in which the glycosylation structures attached to a single 
Kv channel type might vary, thereby altering Kv channel activity. The data 
presented here suggest that Kv1.5, Kv2.1, Kv4.2, and K4.3 activity is modulated 
by N-and O-linked sialic acids. Our lab previously showed that Nav1.5 is less 
sialylated in the neonatal ventricles than the neonatal atria, and this difference in 
Nav1.5 sialylation is responsible for the differences in channel gating 
observed218.Kv channels, including those examined here, may follow a similar 
sialylation pattern in atria and ventricles. This is consistent with our previously 
described data, in which action potential duration was shortened in the neonatal 
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atria compared to the ventricles because of a sialic acid-dependent increase in 
Kv channel activity in the atria. Therefore, as cardiac glycosylation is regulated, 
Kv channel sialylation levels would change, modulating Kv channel gating. This 
cell-specific change in Kv isoform gating would have a direct effect on AP 
repolarization. 
 
As described in this study, altered glycosylation differentially modulates Kv 
channel function. In addition to changes in expression and/or glycosylation, 
mutations in the α- or β-subunit of channel proteins, namely Nav1.5, KvLQT1, 
hERG, and KCNE1 and 2, can result in altered channel function as well. This can 
modulate the cardiac AP, leading to such channelopathies as Long QT 
Syndrome and Brugada Syndrome (see Introduction for details)292. However, 
Nav1.5, KvLQT1, hERG, and KCNE1 and 2 contain extracellular N-glycosylation 
sites22,209,293-296; thus, the normal activity of these channels could be altered by 
changes in glycosylation, producing similar losses or gains of function as that 
observed in the currently identified channelopathies. Furthermore, changes in 
glycosylation of mutant channel proteins could act to exacerbate or correct the 
observed pathological consequence of the mutation. 
 
Kv1.5 encodes the ultra rapid delayed rectifier current, IKur, in human atria122. Due 
to the specificity of IKur, as it is not expressed in human ventricular myocytes or 
Purkinje fibers, modulation of IKur and Kv1.5 is considered a potential target for 
the treatment of atrial arrhythmias297. Therefore, considering the results from this 
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study, altering sialylation of Kv1.5 could be explored as a potential therapy to 
control atrial fibrillation. 
 
The data presented here suggest that Kv2.1, Kv4.2, and Kv4.3 activity is 
modulated by O-linked sialic acids. As formerly discussed, Kv4.2 and Kv4.3 are 
responsible for producing a rapidly activating and inactivating cardiac current, Ito, 
involved in early action potential repolarization (phase 1). A previous report 
indicated that changes in murine ventricular Ito following treatment with an 
enzyme to remove sialic acids may contribute to the extended AP duration and 
increase in early after depolarizations observed217. In diabetic myocytes, the 
expression of Kv4 channels was shown to be reduced, while Kv1.4 expression 
was increased298,299. This may be a compensatory effect of diabetes, as Kv1.4 
channel gating was shown in this study to be unaltered by changes in 
glycosylation (as expressed in CHO cells). Furthermore, Kv2.1, which produces a 
slowly inactivating current, aids in regulation of excitability in cortical and 
hippocampal pyramidal neurons by acting as a suppressor during periods of 
hyperexcitability300,301. Therefore, alterations in Kv2.1 sialylation may disrupt this 
suppressive role and increase the frequency and/or duration of hyperexcitability 
in these neurons. Many potential implications of this study exist beyond that of 
the cardiovascular system.  
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Future Directions 
Here, we showed that aberrant glycosylation modulates gating of Kv channels, 
altering cardiac K+ currents and AP repolarization; in turn, cardiac excitability 
may be impacted. However, much more remains to be done. To acquire a more 
comprehensive understanding, analyses of the contribution of O-glycans must be 
further elucidated. Although O-glycosidase treatment is harsh on the cells 
(because of pre-digestion with multiple enzymes) and somewhat ineffective, it is 
the only means available to investigate the effect of O-glycosylation on AP 
production and Kv channel function. Based on the Kv channel data presented 
here, we would predict that removal of O-glycans would lengthen atrial APD and 
time to peak and shift the voltage-dependence of atrial Kv currents to more 
depolarized potentials, without an effect on ventricular APs or Kv currents. 
Additionally, examination of sodium and calcium currents from murine neonatal 
atria and ventricles should be performed using ST3Gal-IV(-/-) and glycosidase 
treated (neuraminidase, PNGase-F, and O-glycosidase) myocytes. APs and 
potassium, sodium, and calcium currents measured from adult atria and ventricle 
should be tested under the aforementioned experimental conditions. Previous 
studies from our lab suggest that adult atria and ventricles contain more complex 
glycosylation than neonatal ventricular myocytes189; therefore, a larger effect of 
glycosylation may be observed on APs and currents recorded from adult 
myocytes.  
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These experiments also could be performed under pathological conditions, using 
mouse models of diabetes, heart failure, or (inducible) myocardial infarction, for 
example. Another possible project would be to investigate the effect of changing 
glycosylation on neuronal and skeletal muscle conduction pathways throughout 
development and with the onset of disease. All of these experiments, including 
those conducted in the heterologous expression system, should be performed 
under more physiologic temperature conditions—37ºC, as opposed to 22ºC. 
Previous studies have found that changes in temperature can alter the gating 
properties of ion channels302,303. For example, Kv2.1 currents recorded from 
pancreatic β-cells at 22ºC displayed typical slow inactivation rates; however, 
when the temperature was increased to 32-35ºC, these currents exhibited faster 
activation and inactivation kinetics, resembling those currents produced from 
Kv1.4302. Currents measured from hypoglycosylated cardiomyocytes, neurons, 
skeletal muscle cells, and/or transiently transfected CHO cells could be 
examined under hypoxic, acidotic, and ischemic conditions as well. Ito amplitude 
was decreased in ischemic canine ventricular myocytes, as reported in a prior 
study; furthermore, separately induced conditions of hypoxia and acidosis 
reduced Ito amplitude304. Therefore, it would be interesting to observe whether 
reduced glycosylation further diminished potassium, sodium, and calcium current 
amplitude in ischemic excitable cells. 
 
In addition, ECGs should be evaluated in control and ST3Gal-IV(-/-) mice with an 
induced pathology, such as the ones mentioned above. Pharmacologic block or 
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stimulus of vagal inputs in ECG-monitored control and ST3Gal-IV deficient mice 
may provide a clearer understanding of the impact of glycosylation on the beat-
to-beat control of the heart via the autonomic (parasympathetic) nervous system. 
In humans, atrial fibrillation is prevalent in the elderly population; therefore, ECGs 
recorded from aged control and ST3Gal-IV(-/-) mice could be compared to 
determine whether the incidence of atrial fibrillation is increased with a deficiency 
in ST3Gal-IV. Telemetry allows for the recording of not only cardiac conduction 
(ECGs), but also activity level and blood pressure. It would be of interest to note 
whether either of these parameters is altered in healthy or diseased  
ST3Gal-IV(-/-) mice. Optical mapping of the myocardium should be performed on 
ST3Gal-IV(-/-) and littermate control mice as well as those with induced 
pathologies to further elucidate the impact of glycosylation on cardiac excitability. 
Modeling software may provide some insight into the mechanisms contributing to 
the ECG and AP data and may prove useful in determining the next appropriate 
experimental step. 
 
Previously published reports have utilized a technique similar to that of Click 
chemistry to examine O-glycosylation in vivo236,237. In this way, specific azide-
modified sugars can be incorporated into endogenous glycosylation structures 
via tail vein injection. This would allow for detection of specific sugar residues on 
certain proteins. Thus, glycosylation patterns throughout development or 
pathological progression could be observed on various glycoproteins, such as ion 
channels and extracellular matrix proteins. The patterning could be examined in 
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tissues other than the heart, for example in the brain, skeletal muscle, and/or 
liver. The ST3Gal-IV(-/-) and STX(-/-) mouse models also could be utilized to 
understand whether compensatory mechanisms exist to attach some sialic acid, 
albeit at a much lesser amount, to certain proteins.  
 
Although treatment with O-glycosidases is not optimal, these experiments should 
be performed on Kv2.1, Kv4.2, and Kv4.3 to once again confirm that O-
glycosylation exerts an effect on channel activation. Software capable of 
predicting potential O-glycosylation sites and the current Kv channel crystal 
structure could be utilized to limit the number of potential O-glycosylation sites. 
Based upon these data, mutagenesis of the potential sites could be performed to 
allow for confirmation of the data presented in this study (via western blots and 
electrophysiologic studies). These experiments would allow for a more complete 
appreciation of how O-glycosylation and sialylation are regulated (remodeled) 
under pathological and normal developmental states.  
 
Summary 
Here, we show that aberrant glycosylation alters cardiac excitability, with 
changes in sialylation primarily responsible for the observed effects. ECGs 
suggested a trend toward increased arrhythmias in ST3Gal-IV(-/-) mice; 
broadened P waves were exhibited as well. Consistently, atrial APs and Kv 
currents showed glycosylation-dependent changes in duration and gating, 
respectively; ventricular APs and Kv currents were not impacted by changes in 
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glycosylation. Expression of Ito and IK,slow generating channels in differentially 
sialylating cell lines showed depolarizing shifts in activation with reduced N- and 
O-glycosylation, supporting our results in the atrial myocytes.    
 
Changes in glycosylation have been shown to affect multiple systems, including 
the cardiovascular system. The ubiquitous and complex nature of glycosylation 
makes it a viable modulator of protein function. Glycosylation enhances ion 
channel activity, including that of heavily glycosylated Kv channels. Reduced 
glycosylation, specifically sialylation, of atrial Kv currents leads to depolarizing 
shifts in activation, promoting arrhythmicity (at least partially) by lengthening the 
AP. As glycosylation and/or expression of Kv channels is remodeled throughout 
development or with the progression of pathologies, changes in the functional 
effect of Kv currents may occur. Thus, the excitability of cardiac, neuronal, and 
skeletal muscle tissues may be modulated. Changing protein glycosylation 
structures has been largely overlooked as treatment for pathologies such as 
atrial fibrillation. However, if by altering the amount or type of glycans, one might 
enhance or diminish protein activity level and, thus, ameliorate the symptoms of 
associated disorders. Unfortunately, this therapy may only be effective if 
localized or given to patients with global glycosylation disorders, as unsolicited 
side effects may result due to the abundance of cell surface glycans. 
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